{
  "LinkDataSet": {
    "LinkData": [
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ret"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ret proto-oncogene",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 124,
            "CooccurrenceScore": 564228,
            "Article": [
              {
                "PCLID": 36094026,
                "RelevanceScore": 1298570,
                "PMID": 37854153,
                "DOI": "10.21037/tlcr-23-469",
                "PublicationDate": "2023-09-28",
                "IsReview": false,
                "Title": "First-line versus second-line use of pralsetinib in treatment of rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis",
                "Author": "Wenjie Liu, Gengwei Huo, Mengjie Li, Peng Chen",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName": "pralsetinib; prl"
              },
              {
                "PCLID": 39703807,
                "RelevanceScore": 1038856,
                "PMID": 41278989,
                "DOI": "10.1101/2025.10.07.680986",
                "PublicationDate": "2025-10-08",
                "IsReview": false,
                "Title": "RET Receptor Tyrosine Kinase Promotes Breast Cancer Metastasis to the Brain and RET Inhibitors Pralsetinib and Selpercatinib Suppress Breast Cancer Brain Metastases",
                "Author": "Angelina T. Regua, Shivani Bindal, Mariana Najjar, Phi-Long Tran, Joshua Cha, Syed Shahmeer Shams, Hui-Wen Lo",
                "Journal": "bioRxiv : the preprint server for biology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 8219907,
                "RelevanceScore": 1038856,
                "PMID": 34590525,
                "DOI": "10.1177/10781552211040542",
                "PublicationDate": "2021-09-30",
                "IsReview": false,
                "Title": "A contemporary review of rearranged during transfection-selective inhibitors",
                "Author": "Angel W Liu, Connie Liang, Chung-Shien Lee",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35789942,
                "RelevanceScore": 1038856,
                "PMID": 37218138,
                "DOI": "10.4143/crt.2023.403",
                "PublicationDate": "2023-10-15",
                "IsReview": false,
                "Title": "Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement",
                "Author": "Youngkyung Jeon, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Se-Hoon Lee",
                "Journal": "Cancer Research and Treatment",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36227874,
                "RelevanceScore": 1038856,
                "PMID": 38009200,
                "DOI": "10.1089/thy.2023.0363",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study",
                "Author": "Vivek Subbiah, Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schuler, Viola W. Zhu, Julien Hadoux, Giuseppe Curigliano, Lori Wirth, Justin F. Gainor, Guzman Alonso, Douglas Adkins, Yann Godbert, Myung-Ju Ahn, Philippe A. Cassier, Byoung Chul Cho, Chia-Chi Lin, Alena Zalutskaya, Teresa Barata, Peter Trask, Astrid Scalori, Walter Bordogna, Sebastian Heinzmann, Marcia S. Brose",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tnk1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "tyrosine kinase non receptor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 81,
            "CooccurrenceScore": 176770,
            "Article": [
              {
                "PCLID": 5449121,
                "RelevanceScore": 754876,
                "PMID": 34864862,
                "DOI": "10.1093/ajhp/zxab462",
                "PublicationDate": "2021-12-05",
                "IsReview": true,
                "Title": "Pralsetinib: Treatment of metastatic RET fusion–positive non–small cell lung cancer",
                "Author": "Ly Nguyen, Shanada Monestime",
                "Journal": "American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 14278179,
                "RelevanceScore": 694486,
                "PMID": 34258110,
                "DOI": "10.7759/cureus.15441",
                "PublicationDate": "2021-06-04",
                "IsReview": false,
                "Title": "Into the Unknown: A Case of New-Onset Cardiomyopathy in a Patient Treated With Recently Approved Tyrosine Kinase Inhibitor, Pralsetinib",
                "Author": "Alexa Papaila, Alexis T Jacobson",
                "Journal": "Cureus",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35656580,
                "RelevanceScore": 603901,
                "PMID": 37301138,
                "DOI": "10.1016/j.biopha.2023.114995",
                "PublicationDate": "2023-08-01",
                "IsReview": false,
                "Title": "Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance",
                "Author": "Sofia Trocchianesi, Agnese Po, Anna Citarella, Zaira Spinello, Aurelia Rughetti, Zein Mersini Besharat, Tanja Milena Autilio, Valeria Pecce, Antonella Verrienti, Rossella Elisei, Cosimo Durante, Giuseppina Catanzaro, Elisabetta Ferretti",
                "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 29773356,
                "RelevanceScore": 513316,
                "PMID": 32416592,
                "DOI": "10.1016/j.jchromb.2020.122131",
                "PublicationDate": "2020-06-15",
                "IsReview": false,
                "Title": "Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry",
                "Author": "Rahime Şentürk, Yaogeng Wang, Alfred H. Schinkel, Jos H. Beijnen, Rolf W. Sparidans",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36420019,
                "RelevanceScore": 513316,
                "PMID": 38094038,
                "DOI": "10.1159/000535172",
                "PublicationDate": "2023-12-13",
                "IsReview": false,
                "Title": "Cerebrospinal Fluid Concentration of the RET Inhibitor Pralsetinib: A Case Report",
                "Author": "Loek A.W. De Jong, Rolf W. Sparidans, Michel M. van den Heuvel",
                "Journal": "Case Reports in Oncology",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "kif5b"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "kinesin family member 5b",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 34,
            "CooccurrenceScore": 176445,
            "Article": [
              {
                "PCLID": 39034812,
                "RelevanceScore": 1734213,
                "PMID": 40599544,
                "DOI": "10.3389/fgene.2025.1569912",
                "PublicationDate": "2025-06-17",
                "IsReview": false,
                "Title": "Case Report: Successful late-line pralsetinib treatment in an ALK-rearranged lung adenocarcinoma patient with KIF5B-RET fusion resistant to alectinib",
                "Author": "Feng Jin, Chenyang Wang, Fang Yang, Shubin Wang, Fen Wang",
                "Journal": "Frontiers in Genetics",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif5b"
              },
              {
                "PCLID": 38940995,
                "RelevanceScore": 1114851,
                "PMID": 40496186,
                "DOI": "10.1039/d5md00245a",
                "PublicationDate": "2025-08-13",
                "IsReview": false,
                "Title": "Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy",
                "Author": "Ujjwol Khatri, Neetu Dayal, Kofi B. Owusu, Mandeep Kaur Hunjan, Shriya Pandey, Haley Anne Harper, Carli McMahan, Bennett D. Elzey, Tao Shen, Xueqing Hu, Kurt W. Evans, Ahmed El-Sheikh, Seong jun Jo, Frederick W. Holtsberg, M. Javad Aman, Funda Meric-Bernstam, Sukyung Woo, Herman O. Sintim, Jie Wu",
                "Journal": "RSC Medicinal Chemistry",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif5b"
              },
              {
                "PCLID": 34445045,
                "RelevanceScore": 1114851,
                "PMID": 36471407,
                "DOI": "10.1186/s12957-022-02848-z",
                "PublicationDate": "2022-12-06",
                "IsReview": false,
                "Title": "Partial response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: a case report",
                "Author": "Ying Wu, Zhecheng Yan, Juan Pan, Xiaona Chang, Bo Huang, Danju Luo, Rui Meng, Heshui Shi, Jun Fan, Xiu Nie",
                "Journal": "World Journal of Surgical Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif5b"
              },
              {
                "PCLID": 35531263,
                "RelevanceScore": 1114851,
                "PMID": 37525669,
                "DOI": "10.2147/cmar.s414077",
                "PublicationDate": "2023-07-01",
                "IsReview": false,
                "Title": "A Metastatic Pulmonary Sarcomatoid Carcinoma Patient Harboring KIF5B-RET Fusion Responds to First-Line Pralsetinib Treatment: A Case Report",
                "Author": "Hao Qin, Yuxiang Wan, Yuchao Dong, Qinying Sun",
                "Journal": "Cancer Management and Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif5b"
              },
              {
                "PCLID": 38532901,
                "RelevanceScore": 1052915,
                "PMID": 40083593,
                "DOI": "10.3389/fphar.2024.1443609",
                "PublicationDate": "2025-02-27",
                "IsReview": false,
                "Title": "Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report",
                "Author": "Zhe Zhao, Longbin Pang, Surui Liu, Jie Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif5b"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ccdc6"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "coiled-coil domain containing 6",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 29,
            "CooccurrenceScore": 136837,
            "Article": [
              {
                "PCLID": 35679188,
                "RelevanceScore": 1679491,
                "PMID": 37141396,
                "DOI": "10.1093/oncolo/oyad115",
                "PublicationDate": "2023-05-04",
                "IsReview": false,
                "Title": "Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation",
                "Author": "Jing Zhao, Wei Xu, Xiaoli Zhuo, Lei Liu, Junlei Zhang, Fengxian Jiang, Yanru Shen, Yan Lei, Dongsheng Hou, Xiaoyan Lin, Cuiyan Wang, Guobin Fu",
                "Journal": "The Oncologist",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ccdc6"
              },
              {
                "PCLID": 35092322,
                "RelevanceScore": 1379582,
                "PMID": 36451418,
                "DOI": "10.1097/md.0000000000031480",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report",
                "Author": "Linping Gu, Wenxiang Ji, Yunhua Xu, Yuchen Han, Hong Jian",
                "Journal": "Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ccdc6"
              },
              {
                "PCLID": 33946432,
                "RelevanceScore": 1199636,
                "PMID": 35571397,
                "DOI": "10.21037/atm-22-1237",
                "PublicationDate": "2022-04-01",
                "IsReview": false,
                "Title": "Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report",
                "Author": "Yan Meng, Lulu Li, Huan Wang, Xiaofang Chen, Yali Yue, Meiqing Wang, Lingru Meng, Bafei Li, Xiao Li",
                "Journal": "Annals of Translational Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ccdc6"
              },
              {
                "PCLID": 37597151,
                "RelevanceScore": 1019691,
                "PMID": 39139787,
                "DOI": "10.3389/fmed.2024.1402902",
                "PublicationDate": "2024-07-30",
                "IsReview": false,
                "Title": "A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review",
                "Author": "François Poumeaud, Marion Jaffrelot, Carlos Gomez-Roca, Iphigénie Korakis, Giulia Leonardi, Marine Joly, Julien Mazières, Rosine Guimbaud, Nadim Fares, Emily Alouani",
                "Journal": "Frontiers in Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ccdc6"
              },
              {
                "PCLID": 35432075,
                "RelevanceScore": 959709,
                "PMID": 36578928,
                "DOI": "10.3389/fonc.2022.1042525",
                "PublicationDate": "2022-12-12",
                "IsReview": false,
                "Title": "Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma",
                "Author": "Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Vincenzo Maiolo, Marco Ferrari, Filippo Natali, Elisa Lodi Rizzini, Fabio Monari, Erica Solaroli, Antonio De Leo, Thais Maloberti, Maria A. Pantaleo, Dario De Biase, Giovanni Tallini",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ccdc6"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "zmynd10"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "zinc finger mynd-type containing 10",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 135239,
            "Article": [
              {
                "PCLID": 13600687,
                "RelevanceScore": 1159419,
                "PMID": 34099825,
                "DOI": "10.1038/s41698-021-00188-x",
                "PublicationDate": "2021-06-07",
                "IsReview": false,
                "Title": "The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib",
                "Author": "Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 7515310,
                "RelevanceScore": 1159419,
                "PMID": 34586104,
                "DOI": "10.1358/dot.2021.57.9.3306764",
                "PublicationDate": "2021-09-01",
                "IsReview": true,
                "Title": "Pralsetinib for the treatment of non-small cell lung cancer",
                "Journal": "Drugs of today (Barcelona, Spain : 1998)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 19676353,
                "RelevanceScore": 1159419,
                "PMID": 33161056,
                "DOI": "10.1016/j.annonc.2020.10.599",
                "PublicationDate": "2021-02-01",
                "IsReview": false,
                "Title": "Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations",
                "Author": "V. Subbiah, T. Shen, S.S. Terzyan, X. Liu, X. Hu, K.P. Patel, M. Hu, M. Cabanillas, A. Behrang, F. Meric-Bernstam, P.T.T. Vo, B.H.M. Mooers, J. Wu",
                "Journal": "Annals of oncology : official journal of the European Society for Medical Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35679188,
                "RelevanceScore": 1159419,
                "PMID": 37141396,
                "DOI": "10.1093/oncolo/oyad115",
                "PublicationDate": "2023-05-04",
                "IsReview": false,
                "Title": "Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation",
                "Author": "Jing Zhao, Wei Xu, Xiaoli Zhuo, Lei Liu, Junlei Zhang, Fengxian Jiang, Yanru Shen, Yan Lei, Dongsheng Hou, Xiaoyan Lin, Cuiyan Wang, Guobin Fu",
                "Journal": "The Oncologist",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36667151,
                "RelevanceScore": 1159419,
                "PMID": 38261313,
                "DOI": "10.1530/erc-23-0134",
                "PublicationDate": "2024-01-23",
                "IsReview": false,
                "Title": "Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients",
                "Author": "Xiangqian Zheng, Meiyu Fang, Yun Fan, Yuping Sun, Meili Sun, Ankui Yang, Bin Zhang, Qinjiang Liu, Hui Liu, Xiaohong Zhou, Tao Huang, Jianwu Qin, Zhaohui Wang, Mengmeng Qin, Zhenwei Shen, Sheng Yao, Jason Yang, Yu Wang, Ming Gao",
                "Journal": "Endocrine-Related Cancer",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "egfr"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "epidermal growth factor receptor",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 38,
            "CooccurrenceScore": 59697,
            "Article": [
              {
                "PCLID": 34128838,
                "RelevanceScore": 822885,
                "PMID": 35711719,
                "DOI": "10.1016/j.jtocrr.2022.100343",
                "PublicationDate": "2022-06-01",
                "IsReview": false,
                "Title": "Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report",
                "Author": "Zichen Zhao, Chao Su, Weigang Xiu, Weiya Wang, Shasha Zeng, Meijuan Huang, Youling Gong, You Lu, Yan Zhang",
                "Journal": "JTO Clinical and Research Reports",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "egfr"
              },
              {
                "PCLID": 38244496,
                "RelevanceScore": 822885,
                "PMID": 39800214,
                "DOI": "10.1016/j.canlet.2025.217455",
                "PublicationDate": "2025-03-01",
                "IsReview": false,
                "Title": "RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs",
                "Author": "Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Liang",
                "Journal": "Cancer Letters",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "egfr"
              },
              {
                "PCLID": 37936126,
                "RelevanceScore": 470220,
                "PMID": 39495173,
                "DOI": "10.1158/1078-0432.ccr-24-1762",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "YAP Regulates HER3 Signaling–Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers",
                "Author": "Yuki Katayama, Tadaaki Yamada, Keiko Tanimura, Hayato Kawachi, Masaki Ishida, Yohei Matsui, Soichi Hirai, Ryota Nakamura, Kenji Morimoto, Naoki Furuya, Sachiko Arai, Yasuhiro Goto, Yoshihiko Sakata, Kazumi Nishino, Michiko Tsuchiya, Akihiro Tamiya, Go Saito, Satoshi Muto, Takayuki Takeda, Koji Date, Yasuhito Fujisaka, Satoshi Watanabe, Daichi Fujimoto, Hisanori Uehara, Mano Horinaka, Toshiyuki Sakai, Seiji Yano, Shinsaku Tokuda, Koichi Takayama",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38843277,
                "RelevanceScore": 352665,
                "PMID": 40405293,
                "DOI": "10.1186/s13046-025-03392-w",
                "PublicationDate": "2025-05-22",
                "IsReview": false,
                "Title": "AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors",
                "Author": "Daniela Esposito, Claudia Maria Ascione, Stefania Belli, Fabiana Napolitano, Alberto Servetto, Felice Pepe, Umberto Malapelle, Antonino Iaccarino, Giancarlo Troncone, Diletta Barone, Emilio Bria, Roberto Ferrara, Daniele Lorenzini, Giuseppe Lo Russo, Maria Rosa Ghigna, Arianna Marinello, Mihaela Aldea, Benjamin Besse, Luigi Formisano, Roberto Bianco",
                "Journal": "Journal of experimental & clinical cancer research : CR",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "egfr"
              },
              {
                "PCLID": 12936526,
                "RelevanceScore": 323276,
                "PMID": 34505490,
                "DOI": "10.4045/tidsskr.21.0147",
                "PublicationDate": "2021-09-07",
                "IsReview": false,
                "Title": "Lung cancer treated abroad with receptor tyrosine kinase inhibitor",
                "Author": "Inger Johanne Zwicky Eide, Odd Terje Brustugun",
                "Journal": "Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "egfr"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "braf"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "b-raf proto-oncogene, serine/threonine kinase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 22,
            "CooccurrenceScore": 38325,
            "Article": [
              {
                "PCLID": 35432075,
                "RelevanceScore": 439828,
                "PMID": 36578928,
                "DOI": "10.3389/fonc.2022.1042525",
                "PublicationDate": "2022-12-12",
                "IsReview": false,
                "Title": "Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma",
                "Author": "Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Vincenzo Maiolo, Marco Ferrari, Filippo Natali, Elisa Lodi Rizzini, Fabio Monari, Erica Solaroli, Antonio De Leo, Thais Maloberti, Maria A. Pantaleo, Dario De Biase, Giovanni Tallini",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "braf"
              },
              {
                "PCLID": 37225707,
                "RelevanceScore": 380804,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "braf"
              },
              {
                "PCLID": 35541639,
                "RelevanceScore": 333203,
                "PMID": 37207147,
                "DOI": "10.3389/fonc.2023.1141314",
                "PublicationDate": "2023-05-03",
                "IsReview": true,
                "Title": "Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe",
                "Author": "Rossella Elisei, Enrique Grande, Michael C. Kreissl, Sophie Leboulleux, Tarun Puri, Nicolas Fasnacht, Jaume Capdevila",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "braf"
              },
              {
                "PCLID": 10250207,
                "RelevanceScore": 272621,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "braf"
              },
              {
                "PCLID": 38421735,
                "RelevanceScore": 261803,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "braf"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ros1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ros proto-oncogene 1, receptor tyrosine kinase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 15,
            "CooccurrenceScore": 37979,
            "Article": [
              {
                "PCLID": 38356789,
                "RelevanceScore": 893292,
                "PMID": 39907599,
                "DOI": "10.18632/oncotarget.28682",
                "PublicationDate": "2025-02-05",
                "IsReview": false,
                "Title": "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report",
                "Author": "Jenny L. Wu, Wade T. Iams",
                "Journal": "Oncotarget",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ros1"
              },
              {
                "PCLID": 12936526,
                "RelevanceScore": 578012,
                "PMID": 34505490,
                "DOI": "10.4045/tidsskr.21.0147",
                "PublicationDate": "2021-09-07",
                "IsReview": false,
                "Title": "Lung cancer treated abroad with receptor tyrosine kinase inhibitor",
                "Author": "Inger Johanne Zwicky Eide, Odd Terje Brustugun",
                "Journal": "Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ros1"
              },
              {
                "PCLID": 34244735,
                "RelevanceScore": 578012,
                "PMID": 35612671,
                "DOI": "10.1007/s10637-022-01259-x",
                "PublicationDate": "2022-05-25",
                "IsReview": false,
                "Title": "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046",
                "Author": "Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano",
                "Journal": "Investigational New Drugs",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ros1"
              },
              {
                "PCLID": 38421735,
                "RelevanceScore": 450399,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "ros1"
              },
              {
                "PCLID": 1336208,
                "RelevanceScore": 375333,
                "PMID": 34120433,
                "DOI": "10.3779/j.issn.1009-3419.2021.102.22",
                "PublicationDate": "2021-08-20",
                "IsReview": true,
                "Title": "[Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer]",
                "Author": "Yujun Zheng, Wei Jiang, Dongyan Chen, Yanjun Li, Lulu Dai, Lei Huang, Mingji Wang",
                "Journal": "Zhongguo fei ai za zhi = Chinese journal of lung cancer",
                "GeneSymbolName": "ros1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "cd274"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cd274 molecule",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 13,
            "CooccurrenceScore": 32015,
            "Article": [
              {
                "PCLID": 39735543,
                "RelevanceScore": 609925,
                "PMID": 41202951,
                "DOI": "10.1016/j.canlet.2025.218100",
                "PublicationDate": "2026-01-01",
                "IsReview": false,
                "Title": "Identification of a novel RET::FOXJ3 fusion in lung adenocarcinoma associated with lack of response to pralsetinib",
                "Author": "Ping Wang, Hao Xi Lucas Tang, Jiaqin Song, Yuyan Yang, Yao Yao, Lei Xia",
                "Journal": "Cancer Letters",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 37155542,
                "RelevanceScore": 419323,
                "PMID": 38696710,
                "DOI": "10.1097/cad.0000000000001618",
                "PublicationDate": "2024-04-29",
                "IsReview": false,
                "Title": "Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition",
                "Author": "Adam Barsouk, Omar Elghawy, Sara Stone, Aditi Singh",
                "Journal": "Anti-Cancer Drugs",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 33989076,
                "RelevanceScore": 381203,
                "PMID": 35692799,
                "DOI": "10.3389/fonc.2022.864367",
                "PublicationDate": "2022-05-24",
                "IsReview": false,
                "Title": "The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research",
                "Author": "Yan Meng, Yilin Yang, Yujia Fang, Xinqing Lin, Xiaohong Xie, Haiyi Deng, Jianhui Wu, Maolin Zhou, Ni Sun, Zhanhong Xie, Ming Liu, Ming Ouyang, Yinyin Qin, Chunxia Su, Chengzhi Zhou",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36762528,
                "RelevanceScore": 381203,
                "PMID": 38304763,
                "DOI": "10.1016/j.heliyon.2024.e24796",
                "PublicationDate": "2024-01-30",
                "IsReview": false,
                "Title": "Real-world outcomes of chemoimmunotherapy and selective RET inhibitors in Chinese patients with RET fusion-positive non-small cell lung cancer",
                "Author": "Rui Wan, Weihua Li, Zhijie Wang, Jia Zhong, Lin Lin, Jianchun Duan, Jie Wang",
                "Journal": "Heliyon",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35043805,
                "RelevanceScore": 326746,
                "PMID": 35920918,
                "DOI": "10.1007/s00428-022-03390-9",
                "PublicationDate": "2022-08-03",
                "IsReview": false,
                "Title": "Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population",
                "Author": "Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji",
                "Journal": "Virchows Archiv : an international journal of pathology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "calca"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "calcitonin related polypeptide alpha",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 9,
            "CooccurrenceScore": 28682,
            "Article": [
              {
                "PCLID": 38728102,
                "RelevanceScore": 447073,
                "PMID": 40285824,
                "DOI": "10.1007/s11096-025-01917-z",
                "PublicationDate": "2025-04-26",
                "IsReview": false,
                "Title": "Post-marketing safety of pralsetinib: a real-world disproportionality analysis based on the FDA adverse event reporting system database",
                "Author": "Zheng Shi, Keda Shao, Ke Wang, Manyi Xu, Xiayao Yu, Chunwei Xu, Qin Li, Zhengbo Song",
                "Journal": "International Journal of Clinical Pharmacy",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 39554926,
                "RelevanceScore": 447073,
                "PMID": 41145564,
                "DOI": "10.1038/s41598-025-17627-5",
                "PublicationDate": "2025-10-27",
                "IsReview": false,
                "Title": "Real-world FAERS safety analysis of Pralsetinib",
                "Author": "Dongdong Zhang, Yixin Sun, Ying Cai, Peiji Zeng, Yue Wang, Ming Cai, Chengfu Cai",
                "Journal": "Scientific Reports",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38041910,
                "RelevanceScore": 447073,
                "PMID": 39600647,
                "DOI": "10.3389/fonc.2024.1491167",
                "PublicationDate": "2024-11-12",
                "IsReview": false,
                "Title": "A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib",
                "Author": "Yi Yin, Fengli Sun, Youpeng Jin",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38533325,
                "RelevanceScore": 372561,
                "PMID": 40084047,
                "DOI": "10.1530/eo-24-0077",
                "PublicationDate": "2025-02-18",
                "IsReview": true,
                "Title": "Overview of management and therapeutic advances in medullary thyroid cancer",
                "Author": "Mark A Jara, Luciana Audi Castroneves",
                "Journal": "Endocrine oncology (Bristol, England)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38986615,
                "RelevanceScore": 372561,
                "PMID": 40552871,
                "DOI": "10.1097/js9.0000000000002816",
                "PublicationDate": "2025-06-24",
                "IsReview": true,
                "Title": "Dynamic risk stratification-guided management of medullary thyroid carcinoma: integrating surgical precision with RET-targeted therapies and molecular surveillance",
                "Author": "Jiao Zhang, Gianlorenzo Dionigi, Hoon Yub Kim, Hui Sun, Changlin Li",
                "Journal": "International journal of surgery (London, England)",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "kcna1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "potassium voltage-gated channel subfamily a member 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 24500,
            "Article": [
              {
                "PCLID": 25150569,
                "RelevanceScore": 1079748,
                "PMID": 34702125,
                "DOI": "10.1080/17460441.2022.1995351",
                "PublicationDate": "2021-10-27",
                "IsReview": true,
                "Title": "Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer",
                "Author": "Pietro Locantore, Roberto Novizio, Andrea Corsello, Rosa Maria Paragliola, Alfredo Pontecorvi, Salvatore Maria Corsello",
                "Journal": "Expert Opinion on Drug Discovery",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35656580,
                "RelevanceScore": 809811,
                "PMID": 37301138,
                "DOI": "10.1016/j.biopha.2023.114995",
                "PublicationDate": "2023-08-01",
                "IsReview": false,
                "Title": "Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance",
                "Author": "Sofia Trocchianesi, Agnese Po, Anna Citarella, Zaira Spinello, Aurelia Rughetti, Zein Mersini Besharat, Tanja Milena Autilio, Valeria Pecce, Antonella Verrienti, Rossella Elisei, Cosimo Durante, Giuseppina Catanzaro, Elisabetta Ferretti",
                "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 33989076,
                "RelevanceScore": 593862,
                "PMID": 35692799,
                "DOI": "10.3389/fonc.2022.864367",
                "PublicationDate": "2022-05-24",
                "IsReview": false,
                "Title": "The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research",
                "Author": "Yan Meng, Yilin Yang, Yujia Fang, Xinqing Lin, Xiaohong Xie, Haiyi Deng, Jianhui Wu, Maolin Zhou, Ni Sun, Zhanhong Xie, Ming Liu, Ming Ouyang, Yinyin Qin, Chunxia Su, Chengzhi Zhou",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35541639,
                "RelevanceScore": 449895,
                "PMID": 37207147,
                "DOI": "10.3389/fonc.2023.1141314",
                "PublicationDate": "2023-05-03",
                "IsReview": true,
                "Title": "Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe",
                "Author": "Rossella Elisei, Enrique Grande, Michael C. Kreissl, Sophie Leboulleux, Tarun Puri, Nicolas Fasnacht, Jaume Capdevila",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35118347,
                "RelevanceScore": 269937,
                "PMID": 36527599,
                "DOI": "10.1007/s40801-022-00346-y",
                "PublicationDate": "2022-12-17",
                "IsReview": false,
                "Title": "Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study",
                "Author": "Chie Masaki, Kiminori Sugino, Yoshinori Tanizawa, Kenichi Nakamura, Yui Okada, Zhihong Cai, Takahiro Okamoto",
                "Journal": "Drugs - Real World Outcomes"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "kdr"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "kinase insert domain receptor",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 10,
            "CooccurrenceScore": 23829,
            "Article": [
              {
                "PCLID": 25150569,
                "RelevanceScore": 684672,
                "PMID": 34702125,
                "DOI": "10.1080/17460441.2022.1995351",
                "PublicationDate": "2021-10-27",
                "IsReview": true,
                "Title": "Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer",
                "Author": "Pietro Locantore, Roberto Novizio, Andrea Corsello, Rosa Maria Paragliola, Alfredo Pontecorvi, Salvatore Maria Corsello",
                "Journal": "Expert Opinion on Drug Discovery",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 32529027,
                "RelevanceScore": 644397,
                "PMID": 34518294,
                "DOI": "10.1158/1535-7163.mct-21-0127",
                "PublicationDate": "2021-09-13",
                "IsReview": false,
                "Title": "The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation",
                "Author": "Yuchen Jiang, Xia Peng, Yinchun Ji, Yang Dai, Yanfen Fang, Bing Xiong, Wenming Ren, Youhong Hu, Yi Chen, Jing Ai",
                "Journal": "Molecular Cancer Therapeutics",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kdr"
              },
              {
                "PCLID": 38465142,
                "RelevanceScore": 287677,
                "PMID": 40016191,
                "DOI": "10.1038/s41392-025-02155-5",
                "PublicationDate": "2025-02-28",
                "IsReview": false,
                "Title": "Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial",
                "Author": "Dan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, Yanqiu Zhao, Yehui Shi, Yuming Jia, Shundong Cang, Wei Zhang, Jianhua Shi, Jun Chen, Jie Lin, Yunpeng Liu, Jianming Xu, Weiwei Ouyang, Jian Fang, Wu Zhuang, Caigang Liu, Qing Bu, Manxiang Li, Xiangjiao Meng, Meili Sun, Nong Yang, Xiaorong Dong, Yueyin Pan, Xingya Li, Xiujuan Qu, Tongmei Zhang, Xianglin Yuan, Sheng Hu, Wei Guo, Yalun Li, Shengqing Li, Dongying Liu, Feixue Song, Liping Tan, Yan Yu, Xinmin Yu, Aimin Zang, Chang Sun, Qian Zhang, Kai Zou, Mo Dan, Rui-Hua Xu, Hongyun Zhao",
                "Journal": "Signal Transduction and Targeted Therapy"
              },
              {
                "PCLID": 14196272,
                "RelevanceScore": 287677,
                "PMID": 29657135,
                "DOI": "10.1158/2159-8290.cd-18-0338",
                "PublicationDate": "2018-07-01",
                "IsReview": false,
                "Title": "Precision Targeted Therapy with BLU-667 for RET-Driven Cancers",
                "Author": "Vivek Subbiah, Justin F. Gainor, Rami Rahal, Jason D. Brubaker, Joseph L. Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P. Sheets, Douglas Wilson, Kevin J. Wilson, Lucian DiPietro, Paul Fleming, Michael Palmer, Mimi I. Hu, Lori Wirth, Marcia S. Brose, Sai-Hong Ignatius Ou, Matthew Taylor, Elena Garralda, Stephen Miller, Beni Wolf, Christoph Lengauer, Timothy Guzi, Erica K. Evans",
                "Journal": "Cancer Discovery"
              },
              {
                "PCLID": 34903339,
                "RelevanceScore": 287677,
                "PMID": 36275786,
                "DOI": "10.2147/cmar.s340967",
                "PublicationDate": "2022-10-01",
                "IsReview": true,
                "Title": "Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective",
                "Author": "Alice Nervo, Francesca Retta, Alberto Ragni, Alessandro Piovesan, Marco Gallo, Emanuela Arvat",
                "Journal": "Cancer Management and Research",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tp53"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "tumor protein p53",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 23202,
            "Article": [
              {
                "PCLID": 35432075,
                "RelevanceScore": 464999,
                "PMID": 36578928,
                "DOI": "10.3389/fonc.2022.1042525",
                "PublicationDate": "2022-12-12",
                "IsReview": false,
                "Title": "Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma",
                "Author": "Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Vincenzo Maiolo, Marco Ferrari, Filippo Natali, Elisa Lodi Rizzini, Fabio Monari, Erica Solaroli, Antonio De Leo, Thais Maloberti, Maria A. Pantaleo, Dario De Biase, Giovanni Tallini",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "tp53"
              },
              {
                "PCLID": 34919368,
                "RelevanceScore": 348750,
                "PMID": 36437214,
                "DOI": "10.1016/j.cllc.2022.10.005",
                "PublicationDate": "2023-01-01",
                "IsReview": false,
                "Title": "Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report",
                "Author": "Alexia Gazeu, Mylena Aubert, Daniel Pissaloux, Sylvie Lantuejoul, Maurice Pérol, Nadia Ikhlef, Amine Bouhamama, Tatiana Franceschi, Aurélie Swalduz",
                "Journal": "Clinical Lung Cancer",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "tp53"
              },
              {
                "PCLID": 37155542,
                "RelevanceScore": 319687,
                "PMID": 38696710,
                "DOI": "10.1097/cad.0000000000001618",
                "PublicationDate": "2024-04-29",
                "IsReview": false,
                "Title": "Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition",
                "Author": "Adam Barsouk, Omar Elghawy, Sara Stone, Aditi Singh",
                "Journal": "Anti-Cancer Drugs",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "tp53"
              },
              {
                "PCLID": 34758948,
                "RelevanceScore": 290625,
                "PMID": 35978072,
                "DOI": "10.1038/s41598-022-17791-y",
                "PublicationDate": "2022-08-17",
                "IsReview": false,
                "Title": "An integrative pan cancer analysis of RET aberrations and their potential clinical implications",
                "Author": "Lei Zhou, Juanni Li, Xiaofang Zhang, Zhijie Xu, Yuanliang Yan, Kuan Hu",
                "Journal": "Scientific Reports",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "tp53"
              },
              {
                "PCLID": 35940038,
                "RelevanceScore": 207589,
                "PMID": 37347391,
                "DOI": "10.1007/s11523-023-00974-6",
                "PublicationDate": "2023-06-22",
                "IsReview": false,
                "Title": "Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours",
                "Author": "Chih-Chieh Yen, Yu-Min Yeh, Hsuan-Yi Huang, Yu-Lin Ting, Pei-An Fu, Tzu-Chien Lin, I-Ting Liu, Chia-Jui Yen",
                "Journal": "Targeted Oncology",
                "GeneSymbolName": "tp53"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ncoa4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "nuclear receptor coactivator 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 21757,
            "Article": [
              {
                "PCLID": 34746821,
                "RelevanceScore": 682971,
                "PMID": 35962206,
                "DOI": "10.1038/s41591-022-01931-y",
                "PublicationDate": "2022-08-12",
                "IsReview": false,
                "Title": "Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial",
                "Author": "Vivek Subbiah, Philippe A. Cassier, Salvatore Siena, Elena Garralda, Luis Paz-Ares, Pilar Garrido, Ernest Nadal, Jacqueline Vuky, Gilberto Lopes, Gregory P. Kalemkerian, Daniel W. Bowles, Mahesh Seetharam, Jianhua Chang, Hui Zhang, Jennifer Green, Alena Zalutskaya, Martin Schuler, Yun Fan, Giuseppe Curigliano",
                "Journal": "Nature Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ncoa4"
              },
              {
                "PCLID": 31188897,
                "RelevanceScore": 626057,
                "PMID": 33272981,
                "DOI": "10.1158/1078-0432.ccr-20-3208",
                "PublicationDate": "2021-03-01",
                "IsReview": false,
                "Title": "A Performance Comparison of Commonly Used Assays to Detect RET Fusions",
                "Author": "Soo-Ryum Yang, Umut Aypar, Ezra Y. Rosen, Douglas A. Mata, Ryma Benayed, Kerry Mullaney, Gowtham Jayakumaran, Yanming Zhang, Denise Frosina, Alexander Drilon, Marc Ladanyi, Achim A. Jungbluth, Natasha Rekhtman, Jaclyn F. Hechtman",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ncoa4"
              },
              {
                "PCLID": 36762528,
                "RelevanceScore": 569143,
                "PMID": 38304763,
                "DOI": "10.1016/j.heliyon.2024.e24796",
                "PublicationDate": "2024-01-30",
                "IsReview": false,
                "Title": "Real-world outcomes of chemoimmunotherapy and selective RET inhibitors in Chinese patients with RET fusion-positive non-small cell lung cancer",
                "Author": "Rui Wan, Weihua Li, Zhijie Wang, Jia Zhong, Lin Lin, Jianchun Duan, Jie Wang",
                "Journal": "Heliyon",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ncoa4"
              },
              {
                "PCLID": 3331193,
                "RelevanceScore": 237143,
                "PMID": 31715421,
                "DOI": "10.1016/j.ctrv.2019.101911",
                "PublicationDate": "2019-12-01",
                "IsReview": true,
                "Title": "RET fusions in solid tumors",
                "Author": "Andrew Y. Li, Michael G. McCusker, Alessandro Russo, Katherine A. Scilla, Allison Gittens, Katherine Arensmeyer, Ranee Mehra, Vincenzo Adamo, Christian Rolfo",
                "Journal": "Cancer Treatment Reviews",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ncoa4"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 129351,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology",
                "GeneSymbolName": "ncoa4"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "erbb2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "erb-b2 receptor tyrosine kinase 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 11,
            "CooccurrenceScore": 16824,
            "Article": [
              {
                "PCLID": 17674211,
                "RelevanceScore": 491288,
                "PMID": 34156585,
                "DOI": "10.1007/s11060-021-03789-5",
                "PublicationDate": "2021-06-22",
                "IsReview": true,
                "Title": "US Food and Drug Administration regulatory updates in neuro-oncology",
                "Author": "Gautam U. Mehta, Amy K. Barone, Diana Bradford, Erin Larkins, Janice Kim, Lee Pai-Scherf, Adnan Jaigirdar, Mirat Shah, Suparna Wedam, Laleh Amiri-Kordestani, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Harpreet Singh",
                "Journal": "Journal of Neuro-Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 39703807,
                "RelevanceScore": 393030,
                "PMID": 41278989,
                "DOI": "10.1101/2025.10.07.680986",
                "PublicationDate": "2025-10-08",
                "IsReview": false,
                "Title": "RET Receptor Tyrosine Kinase Promotes Breast Cancer Metastasis to the Brain and RET Inhibitors Pralsetinib and Selpercatinib Suppress Breast Cancer Brain Metastases",
                "Author": "Angelina T. Regua, Shivani Bindal, Mariana Najjar, Phi-Long Tran, Joshua Cha, Syed Shahmeer Shams, Hui-Wen Lo",
                "Journal": "bioRxiv : the preprint server for biology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 6157098,
                "RelevanceScore": 307055,
                "PMID": 34083237,
                "DOI": "10.1158/1078-0432.ccr-20-5026",
                "PublicationDate": "2021-06-03",
                "IsReview": false,
                "Title": "Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma",
                "Author": "Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "erbb2"
              },
              {
                "PCLID": 20367522,
                "RelevanceScore": 267367,
                "PMID": 33513356,
                "DOI": "10.1016/j.phrs.2021.105463",
                "PublicationDate": "2021-03-01",
                "IsReview": true,
                "Title": "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
                "Author": "Robert Roskoski",
                "Journal": "Pharmacological Research",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36366594,
                "RelevanceScore": 188957,
                "PMID": 38011864,
                "DOI": "10.1055/s-0043-1776782",
                "PublicationDate": "2023-11-27",
                "IsReview": true,
                "Title": "Management of Brain Metastases: A Review of Novel Therapies",
                "Author": "Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W. McDermott, Manmeet S. Ahluwalia",
                "Journal": "Seminars in Neurology",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pik3ca"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 6,
            "CooccurrenceScore": 14658,
            "Article": [
              {
                "PCLID": 39667339,
                "RelevanceScore": 526878,
                "PMID": 41244832,
                "DOI": "10.3389/fphar.2025.1671798",
                "PublicationDate": "2025-10-31",
                "IsReview": false,
                "Title": "The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production",
                "Author": "Lingyun Ma, Hang Gong, Wei Sun, Jialing Deng, Qinghua Zhang, Jianzhao Niu, Huimin Sun, Xue Han, Tingting Du, Nina Xue, Ming Ji, Qian Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38128141,
                "RelevanceScore": 464892,
                "PMID": 39692337,
                "DOI": "10.1177/10781552241304000",
                "PublicationDate": "2024-12-18",
                "IsReview": false,
                "Title": "Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib",
                "Author": "Alanna Lehman, Anthony Perissinotti, Sam Aitken",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 39141314,
                "RelevanceScore": 340921,
                "PMID": 40702584,
                "DOI": "10.1186/s40364-025-00809-8",
                "PublicationDate": "2025-07-23",
                "IsReview": false,
                "Title": "Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study",
                "Author": "Chang Lu, Chong-Rui Xu, Yi-Chen Zhang, E-E Ke, Yue-Li Sun, Xiao-Yan Bai, Zhi-Hong Chen, Jian Su, Yu Deng, Ting Hou, Fei Zhao, Min Li, Bin-Chao Wang, Hai-Yan Tu, Zhen Wang, Xu-Chao Zhang, Hua-Jun Chen, Jin-Ji Yang, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu",
                "Journal": "Biomarker Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "pik3ca"
              },
              {
                "PCLID": 34743348,
                "RelevanceScore": 309928,
                "PMID": 35957881,
                "DOI": "10.3389/fonc.2022.932353",
                "PublicationDate": "2022-07-25",
                "IsReview": true,
                "Title": "RET signaling pathway and RET inhibitors in human cancer",
                "Author": "Angelina T. Regua, Mariana Najjar, Hui-Wen Lo",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 167878,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pdcd1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "programmed cell death 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 13908,
            "Article": [
              {
                "PCLID": 38373198,
                "RelevanceScore": 452695,
                "PMID": 39926433,
                "DOI": "10.3389/fmed.2025.1467871",
                "PublicationDate": "2025-01-24",
                "IsReview": false,
                "Title": "Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer",
                "Author": "Lei Wang, Yafei You, Wenzhuo He, Yu Hou, Lan Li, Li Wang, Chang Jiang, Jiahong Yi, Yaoxiong Xia, Liangping Xia",
                "Journal": "Frontiers in Medicine",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 39709776,
                "RelevanceScore": 414971,
                "PMID": 41278287,
                "DOI": "10.3389/fonc.2025.1683624",
                "PublicationDate": "2025-11-06",
                "IsReview": false,
                "Title": "Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer",
                "Author": "Yulu Zhou, Junjie Cao, Siqi Zhang, Mingjun Sun, Yaqi Zhang, Songzhe Li, Zining Luo, Pengyu Wang, Jiebin Xie",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35043805,
                "RelevanceScore": 269461,
                "PMID": 35920918,
                "DOI": "10.1007/s00428-022-03390-9",
                "PublicationDate": "2022-08-03",
                "IsReview": false,
                "Title": "Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population",
                "Author": "Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji",
                "Journal": "Virchows Archiv : an international journal of pathology"
              },
              {
                "PCLID": 35580814,
                "RelevanceScore": 230539,
                "PMID": 37543550,
                "DOI": "10.1245/s10434-023-14031-z",
                "PublicationDate": "2023-08-05",
                "IsReview": false,
                "Title": "The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study",
                "Author": "Jia-ying Chen, Nai-si Huang, Wen-jun Wei, Jia-qian Hu, Yi-ming Cao, Qiang Shen, Zhong-wu Lu, Yu-long Wang, Yu Wang, Qing-hai Ji",
                "Journal": "Annals of Surgical Oncology"
              },
              {
                "PCLID": 35033898,
                "RelevanceScore": 157186,
                "PMID": 36639452,
                "DOI": "10.1038/s41571-022-00718-x",
                "PublicationDate": "2023-01-13",
                "IsReview": true,
                "Title": "At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC",
                "Author": "Itziar Otano, Alvaro C. Ucero, Jon Zugazagoitia, Luis Paz-Ares",
                "Journal": "Nature reviews. Clinical oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ceacam5"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cea cell adhesion molecule 5",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 12955,
            "Article": [
              {
                "PCLID": 38986615,
                "RelevanceScore": 396164,
                "PMID": 40552871,
                "DOI": "10.1097/js9.0000000000002816",
                "PublicationDate": "2025-06-24",
                "IsReview": true,
                "Title": "Dynamic risk stratification-guided management of medullary thyroid carcinoma: integrating surgical precision with RET-targeted therapies and molecular surveillance",
                "Author": "Jiao Zhang, Gianlorenzo Dionigi, Hoon Yub Kim, Hui Sun, Changlin Li",
                "Journal": "International journal of surgery (London, England)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36331814,
                "RelevanceScore": 396164,
                "PMID": 37600327,
                "DOI": "10.3892/ol.2023.13993",
                "PublicationDate": "2023-08-02",
                "IsReview": false,
                "Title": "Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report",
                "Author": "Yinghui Bi, Chaoran Xia, Xinglin Zhang, Haixin Liu",
                "Journal": "Oncology Letters",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 34770343,
                "RelevanceScore": 282974,
                "PMID": 36799965,
                "DOI": "10.1007/s00104-023-01824-x",
                "PublicationDate": "2023-05-01",
                "IsReview": true,
                "Title": "[Hereditary medullary thyroid cancer]",
                "Author": "V Fendrich, A Zahn",
                "Journal": "Chirurgie (Heidelberg, Germany)"
              },
              {
                "PCLID": 38545970,
                "RelevanceScore": 220091,
                "PMID": 40102262,
                "DOI": "10.1007/978-3-031-80396-3_11",
                "PublicationDate": "2025-01-01",
                "IsReview": true,
                "Title": "Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients",
                "Author": "Friedhelm Raue, Karin Frank-Raue",
                "Journal": "Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ec:2.6.1.1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "aspartate transaminase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 12398,
            "Article": [
              {
                "PCLID": 37823775,
                "RelevanceScore": 400519,
                "PMID": 39372206,
                "DOI": "10.3389/fphar.2024.1424980",
                "PublicationDate": "2024-09-20",
                "IsReview": false,
                "Title": "Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system",
                "Author": "Qiong Jie, Yuanyuan Li, Li Jing, Jinjin Chen, Yang Li",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38373198,
                "RelevanceScore": 400519,
                "PMID": 39926433,
                "DOI": "10.3389/fmed.2025.1467871",
                "PublicationDate": "2025-01-24",
                "IsReview": false,
                "Title": "Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer",
                "Author": "Lei Wang, Yafei You, Wenzhuo He, Yu Hou, Lan Li, Li Wang, Chang Jiang, Jiahong Yi, Yaoxiong Xia, Liangping Xia",
                "Journal": "Frontiers in Medicine",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38084636,
                "RelevanceScore": 333766,
                "PMID": 39630530,
                "DOI": "10.1089/thy.2024.0495",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma",
                "Author": "Sarah Hamidi, Sireesha Yedururi, Mimi I. Hu, Naifa L. Busaidy, Steven I. Sherman, Camilo Jimenez, Elizabeth G. Grubbs, Anastasios Maniakas, Mark E. Zafereo, Vivek Subbiah, Steven G. Waguespack",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 238404,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "cyp3a4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cytochrome p450 family 3 subfamily a member 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 12387,
            "Article": [
              {
                "PCLID": 36928484,
                "RelevanceScore": 1315798,
                "PMID": 38481038,
                "DOI": "10.1002/psp4.13114",
                "PublicationDate": "2024-03-13",
                "IsReview": false,
                "Title": "Understanding <scp>CYP3A4</scp> and P‐gp mediated <scp>drug–drug</scp> interactions through <scp>PBPK</scp> modeling – Case example of pralsetinib",
                "Author": "Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen",
                "Journal": "CPT: Pharmacometrics & Systems Pharmacology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cyp3a4"
              },
              {
                "PCLID": 8246211,
                "RelevanceScore": 996817,
                "PMID": 34450308,
                "DOI": "10.1016/j.phrs.2021.105850",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "ABCB1 and ABCG2, but not CYP3A4 limit oral availability and brain accumulation of the RET inhibitor pralsetinib",
                "Author": "Yaogeng Wang, Rolf W. Sparidans, Sander Potters, Maria C. Lebre, Jos H. Beijnen, Alfred H. Schinkel",
                "Journal": "Pharmacological Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cyp3a4"
              },
              {
                "PCLID": 34950047,
                "RelevanceScore": 478472,
                "PMID": 36572992,
                "DOI": "10.1177/10781552221147500",
                "PublicationDate": "2022-12-26",
                "IsReview": true,
                "Title": "An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)",
                "Author": "Vanessa Quang Nguyen, Marc Geirnaert",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cyp3a4"
              },
              {
                "PCLID": 38984784,
                "RelevanceScore": 42418,
                "PMID": 40549292,
                "DOI": "10.1007/s11030-025-11260-0",
                "PublicationDate": "2025-06-23",
                "IsReview": true,
                "Title": "Pyrazole in drug development: a medicinal-chemistry based analysis of USFDA-approved drugs in last decade",
                "Author": "Nisha Bansal, Elagandhula Sathish, M. Arockia Babu, Ganesh Bushi, Abhay M. Gaidhane, Thakur Gurjeet Singh, Damini Singh, Glowi Alasiri, Mohammad Fareed, Bhupinder Kumar",
                "Journal": "Molecular Diversity",
                "GeneSymbolName": "cyp3a4"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ank3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ankyrin 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 12290,
            "Article": [
              {
                "PCLID": 36871056,
                "RelevanceScore": 696231,
                "PMID": 38420011,
                "DOI": "10.3389/fonc.2024.1307458",
                "PublicationDate": "2024-02-07",
                "IsReview": false,
                "Title": "Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC",
                "Author": "Elisa De Carlo, Elisa Bertoli, Monica Schiappacassi, Brigida Stanzione, Alessandro Del Conte, Roberto Doliana, Michele Spina, Alessandra Bearz",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ank3"
              },
              {
                "PCLID": 37007009,
                "RelevanceScore": 542517,
                "PMID": 38539256,
                "DOI": "10.1186/s13000-024-01478-1",
                "PublicationDate": "2024-03-27",
                "IsReview": false,
                "Title": "Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report",
                "Author": "Tillmann Bedau, Carina Heydt, Udo Siebolts, Thomas Zander, Max Kraemer, Heike Loeser, Reinhard Buettner, Alexander Quaas",
                "Journal": "Diagnostic Pathology",
                "GeneSymbolName": "ank3"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 143849,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology",
                "GeneSymbolName": "ank3"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "eml4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "emap like 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 11498,
            "Article": [
              {
                "PCLID": 37161097,
                "RelevanceScore": 725304,
                "PMID": 38698976,
                "DOI": "10.1016/j.heliyon.2024.e29928",
                "PublicationDate": "2024-05-15",
                "IsReview": false,
                "Title": "RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report",
                "Author": "Huan Yan, Liang Zeng, Yongchang Zhang",
                "Journal": "Heliyon",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "eml4"
              },
              {
                "PCLID": 36897636,
                "RelevanceScore": 511432,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "eml4"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 126801,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology",
                "GeneSymbolName": "eml4"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tpo"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "thyroid peroxidase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 11479,
            "Article": [
              {
                "PCLID": 34244735,
                "RelevanceScore": 957779,
                "PMID": 35612671,
                "DOI": "10.1007/s10637-022-01259-x",
                "PublicationDate": "2022-05-25",
                "IsReview": false,
                "Title": "The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046",
                "Author": "Matteo Repetto, Edoardo Crimini, Liliana Ascione, Luca Boscolo Bielo, Carmen Belli, Giuseppe Curigliano",
                "Journal": "Investigational New Drugs",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35461047,
                "RelevanceScore": 718334,
                "PMID": 36557971,
                "DOI": "10.3390/molecules27248839",
                "PublicationDate": "2022-12-13",
                "IsReview": true,
                "Title": "Precious Gene: The Application of RET-Altered Inhibitors",
                "Author": "Qitao Gou, Xiaochuan Gan, Longhao Li, Qiheng Gou, Tao Zhang",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 39348705,
                "RelevanceScore": 209039,
                "PMID": 40913959,
                "DOI": "10.1016/j.bioorg.2025.108948",
                "PublicationDate": "2025-10-01",
                "IsReview": true,
                "Title": "Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies",
                "Author": "Ting Wang, Wenjie Jiang, Liyan Yang, Jinqi Li, Yiqi Sun, Jianyou Shi",
                "Journal": "Bioorganic Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pdgfrb"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "platelet derived growth factor receptor beta",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 11467,
            "Article": [
              {
                "PCLID": 38504091,
                "RelevanceScore": 523404,
                "PMID": 40063337,
                "DOI": "10.1080/07391102.2025.2472231",
                "PublicationDate": "2025-03-10",
                "IsReview": false,
                "Title": "Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer",
                "Author": "Darakhshan Parveen, Faizul Azam, M. Mumtaz Alam, Ruhi Ali, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Shyama Charan, Suruchi Khanna, Mohd. Parvez, Mohammad Shaquiquzzaman",
                "Journal": "Journal of Biomolecular Structure and Dynamics",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35207674,
                "RelevanceScore": 339873,
                "PMID": 36131239,
                "DOI": "10.1186/s12885-022-10081-w",
                "PublicationDate": "2022-09-21",
                "IsReview": false,
                "Title": "Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer",
                "Author": "Alicja Rączkowska, Iwona Paśnik, Michał Kukiełka, Marcin Nicoś, Magdalena A. Budzinska, Tomasz Kucharczyk, Justyna Szumiło, Paweł Krawczyk, Nicola Crosetto, Ewa Szczurek",
                "Journal": "BMC Cancer",
                "GeneSymbolName": "pdgfrb"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 183008,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 84968,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35451621,
                "RelevanceScore": 62939,
                "PMID": 36905915,
                "DOI": "10.1016/j.ejmech.2023.115237",
                "PublicationDate": "2023-05-05",
                "IsReview": false,
                "Title": "Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors",
                "Author": "Kaifu Wu, Rui He, Zongyang Li, Kongxi Qiu, Guorong Xiao, Lijie Peng, Xiangbao Meng, Canhui Zheng, Zhang Zhang, Qian Cai",
                "Journal": "European Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "taf"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "protein bel-1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 10537,
            "Article": [
              {
                "PCLID": 36586242,
                "RelevanceScore": 957852,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "taf"
              },
              {
                "PCLID": 35947600,
                "RelevanceScore": 919538,
                "PMID": 37071495,
                "DOI": "10.1158/0008-5472.can-22-3484",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer",
                "Author": "Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt, Diana Fandino, Craig T. Vollert, Purba Singh, Mohammad A. Alzubi, Anna Malovannaya, Lacey E. Dobrolecki, Michael T. Lewis, Shunqiang Li, Charles E. Foulds, Matthew J. Ellis",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "taf"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "abcb1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "atp binding cassette subfamily b member 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 10497,
            "Article": [
              {
                "PCLID": 8246211,
                "RelevanceScore": 1154527,
                "PMID": 34450308,
                "DOI": "10.1016/j.phrs.2021.105850",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "ABCB1 and ABCG2, but not CYP3A4 limit oral availability and brain accumulation of the RET inhibitor pralsetinib",
                "Author": "Yaogeng Wang, Rolf W. Sparidans, Sander Potters, Maria C. Lebre, Jos H. Beijnen, Alfred H. Schinkel",
                "Journal": "Pharmacological Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "abcb1"
              },
              {
                "PCLID": 36928484,
                "RelevanceScore": 1154527,
                "PMID": 38481038,
                "DOI": "10.1002/psp4.13114",
                "PublicationDate": "2024-03-13",
                "IsReview": false,
                "Title": "Understanding <scp>CYP3A4</scp> and P‐gp mediated <scp>drug–drug</scp> interactions through <scp>PBPK</scp> modeling – Case example of pralsetinib",
                "Author": "Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen",
                "Journal": "CPT: Pharmacometrics & Systems Pharmacology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 37270700,
                "RelevanceScore": 1154527,
                "PMID": 38807449,
                "DOI": "10.1111/cts.13818",
                "PublicationDate": "2024-05-28",
                "IsReview": false,
                "Title": "Impact of P‐gp inhibition on systemic exposure of pralsetinib and dosing considerations",
                "Author": "Julia Suchomel, Priya Agarwal, Doreen Anders, Kevin Hughes, Yang Tang, Rucha Sane, Astrid Scalori, Sunil Sharma, Sravanthi Cheeti",
                "Journal": "Clinical and Translational Science",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ec:2.7.10.1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "receptor protein-tyrosine kinase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 10349,
            "Article": [
              {
                "PCLID": 35829919,
                "RelevanceScore": 663967,
                "PMID": 37131086,
                "DOI": "10.1007/s11684-023-0985-y",
                "PublicationDate": "2023-04-01",
                "IsReview": true,
                "Title": "Progress and challenges in RET-targeted cancer therapy",
                "Author": "Xueqing Hu, Ujjwol Khatri, Tao Shen, Jie Wu",
                "Journal": "Frontiers of Medicine",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36629271,
                "RelevanceScore": 431148,
                "PMID": 38231404,
                "DOI": "10.1007/s00108-023-01635-6",
                "PublicationDate": "2024-03-01",
                "IsReview": true,
                "Title": "[Precision medicine in endocrinology exemplified by medullary thyroid cancer]",
                "Author": "Tim Brandenburg, Yara Maria Machlah, Dagmar Führer",
                "Journal": "Innere Medizin (Heidelberg, Germany)"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "fgfr3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "fibroblast growth factor receptor 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 10192,
            "Article": [
              {
                "PCLID": 37155542,
                "RelevanceScore": 568675,
                "PMID": 38696710,
                "DOI": "10.1097/cad.0000000000001618",
                "PublicationDate": "2024-04-29",
                "IsReview": false,
                "Title": "Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition",
                "Author": "Adam Barsouk, Omar Elghawy, Sara Stone, Aditi Singh",
                "Journal": "Anti-Cancer Drugs",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "fgfr3"
              },
              {
                "PCLID": 35709787,
                "RelevanceScore": 236948,
                "PMID": 37000317,
                "DOI": "10.1007/s10495-023-01830-8",
                "PublicationDate": "2023-03-31",
                "IsReview": false,
                "Title": "MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma",
                "Author": "Boqiang Zhong, Youzhi Wang, Yihao Liao, Jiaming Liang, Keke Wang, Diansheng Zhou, Yang Zhao, Ning Jiang",
                "Journal": "Apoptosis : an international journal on programmed cell death",
                "GeneSymbolName": "fgfr3"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 129244,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology",
                "GeneSymbolName": "fgfr3"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 92317,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 76931,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "rb1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "rb transcriptional corepressor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 10006,
            "Article": [
              {
                "PCLID": 36294801,
                "RelevanceScore": 334281,
                "PMID": 38057798,
                "DOI": "10.1186/s12890-023-02799-5",
                "PublicationDate": "2023-12-06",
                "IsReview": false,
                "Title": "Whole-exome sequencing explored mechanism of selpercatinib resistance in RET-rearranged lung adenocarcinoma transformation into small-cell lung cancer: a case report",
                "Author": "Yan Peng, Zhu Zheng, Wang Zewen, Liu Yanan, Zhang Mingyan, Sun Meili",
                "Journal": "BMC Pulmonary Medicine",
                "GeneSymbolName": "rb1"
              },
              {
                "PCLID": 36470598,
                "RelevanceScore": 334281,
                "PMID": 37653509,
                "DOI": "10.1186/s13019-023-02349-4",
                "PublicationDate": "2023-08-31",
                "IsReview": true,
                "Title": "Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature",
                "Author": "Zirui Zhu, You Liu, Hengliang Xu, Haoyong Ning, Yanmin Xia, Leilei Shen",
                "Journal": "Journal of Cardiothoracic Surgery",
                "GeneSymbolName": "rb1"
              },
              {
                "PCLID": 35274516,
                "RelevanceScore": 185712,
                "PMID": 36059009,
                "DOI": "10.1186/s12967-022-03593-3",
                "PublicationDate": "2022-09-04",
                "IsReview": false,
                "Title": "RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer",
                "Author": "Chunyue Wang, Zhenlong Zhang, Yulan Sun, Song Wang, Mengmeng Wu, Qiuxiang Ou, Yang Xu, Zhiming Chen, Yang Shao, Hong Liu, Peifeng Hou",
                "Journal": "Journal of Translational Medicine",
                "GeneSymbolName": "rb1"
              },
              {
                "PCLID": 38889347,
                "RelevanceScore": 146248,
                "PMID": 40452844,
                "DOI": "10.3389/fonc.2025.1477910",
                "PublicationDate": "2025-05-16",
                "IsReview": false,
                "Title": "RET fusion driven (RETfus+) non-small cell lung cancer: a comprehensive genomic profiling study with histologic correlation",
                "Author": "Prashanth Ashok Kumar, Michael Connolly, Alina Basnet, Dean Pavlick, Richard Huang, Steven Graziano, Jeffrey Ross",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "rb1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "mir8070"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "microrna 8070",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 10001,
            "Article": [
              {
                "PCLID": 35429877,
                "RelevanceScore": 2000000,
                "PMID": 36226049,
                "DOI": "10.3389/fonc.2022.1113289",
                "PublicationDate": "2022-09-26",
                "IsReview": false,
                "Title": "Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient",
                "Author": "Sha-Sha Wang, Fang Wang, Zhen Zeng, Fang Gao, Huan-Huan Liu, Hui-Na Wang, Yi Hu, Hai-Feng Qin",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "mir8070"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "mir4299"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "microrna 4299",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 9724,
            "Article": [
              {
                "PCLID": 35429877,
                "RelevanceScore": 1944647,
                "PMID": 36226049,
                "DOI": "10.3389/fonc.2022.1113289",
                "PublicationDate": "2022-09-26",
                "IsReview": false,
                "Title": "Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient",
                "Author": "Sha-Sha Wang, Fang Wang, Zhen Zeng, Fang Gao, Huan-Huan Liu, Hui-Na Wang, Yi Hu, Hai-Feng Qin",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "mir4299"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ntrk1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "neurotrophic receptor tyrosine kinase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 9602,
            "Article": [
              {
                "PCLID": 37224886,
                "RelevanceScore": 549852,
                "PMID": 38744018,
                "DOI": "10.1016/j.bmc.2024.117749",
                "PublicationDate": "2024-05-15",
                "IsReview": false,
                "Title": "Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors",
                "Author": "Baku Acharya, Debasmita Saha, Noemi Garcia Garcia, Daniel Armstrong, Baha'a Jabali, Maha Hanafi, Brendan Frett, Katie Rose Ryan",
                "Journal": "Bioorganic & Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 305474,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35210090,
                "RelevanceScore": 229105,
                "PMID": 36605433,
                "DOI": "10.3389/fonc.2022.1099280",
                "PublicationDate": "2022-12-20",
                "IsReview": true,
                "Title": "Molecular features of aggressive thyroid cancer",
                "Author": "Giusy Elia, Armando Patrizio, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Eugenia Balestri, Chiara Botrini, Licia Rugani, Salvatore Benvenga, Gabriele Materazzi, Claudio Spinelli, Alessandro Antonelli, Poupak Fallahi, Silvia Martina Ferrari",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 81823,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "mab21l4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "mab-21 like 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 9465,
            "Article": [
              {
                "PCLID": 34035054,
                "RelevanceScore": 946392,
                "PMID": 35705526,
                "DOI": "10.1158/0008-5472.can-22-0047",
                "PublicationDate": "2022-06-15",
                "IsReview": false,
                "Title": "MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET",
                "Author": "Ankit Srivastava, Cristina Tommasi, Dane Sessions, Angela Mah, Tomas Bencomo, Jasmine M. Garcia, Tiffany Jiang, Michael Lee, Joseph Y. Shen, Lek Wei Seow, Audrey Nguyen, Kimal Rajapakshe, Cristian Coarfa, Kenneth Y. Tsai, Vanessa Lopez-Pajares, Carolyn S. Lee",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "akt1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "akt serine/threonine kinase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 9037,
            "Article": [
              {
                "PCLID": 39667339,
                "RelevanceScore": 453844,
                "PMID": 41244832,
                "DOI": "10.3389/fphar.2025.1671798",
                "PublicationDate": "2025-10-31",
                "IsReview": false,
                "Title": "The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production",
                "Author": "Lingyun Ma, Hang Gong, Wei Sun, Jialing Deng, Qinghua Zhang, Jianzhao Niu, Huimin Sun, Xue Han, Tingting Du, Nina Xue, Ming Ji, Qian Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38128141,
                "RelevanceScore": 320360,
                "PMID": 39692337,
                "DOI": "10.1177/10781552241304000",
                "PublicationDate": "2024-12-18",
                "IsReview": false,
                "Title": "Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib",
                "Author": "Alanna Lehman, Anthony Perissinotti, Sam Aitken",
                "Journal": "Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 34743348,
                "RelevanceScore": 266967,
                "PMID": 35957881,
                "DOI": "10.3389/fonc.2022.932353",
                "PublicationDate": "2022-07-25",
                "IsReview": true,
                "Title": "RET signaling pathway and RET inhibitors in human cancer",
                "Author": "Angelina T. Regua, Mariana Najjar, Hui-Wen Lo",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 102680,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "gdnf"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "glial cell derived neurotrophic factor",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 9010,
            "Article": [
              {
                "PCLID": 38047756,
                "RelevanceScore": 389189,
                "PMID": 39610047,
                "DOI": "10.1111/cpr.13758",
                "PublicationDate": "2024-11-28",
                "IsReview": false,
                "Title": "Glial cell line derived neurotrophic factor (<scp>GDNF</scp>) induces mucosal healing via intestinal stem cell niche activation",
                "Author": "Marius Hörner, Natalie Burkard, Matthias Kelm, Antonia Leist, Thekla Selig, Catherine Kollmann, Michael Meir, Christoph Otto, Christoph‐Thomas Germer, Kai Kretzschmar, Sven Flemming, Nicolas Schlegel",
                "Journal": "Cell Proliferation",
                "GeneSymbolName": "gdnf"
              },
              {
                "PCLID": 3327127,
                "RelevanceScore": 324324,
                "PMID": 31711124,
                "DOI": "10.1093/carcin/bgz184",
                "PublicationDate": "2019-11-11",
                "IsReview": true,
                "Title": "REToma: a cancer subtype with a shared driver oncogene",
                "Author": "Takashi Kohno, Junya Tabata, Takashi Nakaoku",
                "Journal": "Carcinogenesis"
              },
              {
                "PCLID": 33932505,
                "RelevanceScore": 302702,
                "PMID": 35618883,
                "DOI": "10.1038/s41380-022-01554-2",
                "PublicationDate": "2022-05-26",
                "IsReview": false,
                "Title": "Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia",
                "Author": "Kärt Mätlik, Daniel R. Garton, Ana R. Montaño-Rodríguez, Soophie Olfat, Feride Eren, Laoise Casserly, Anastasios Damdimopoulos, Anne Panhelainen, L. Lauriina Porokuokka, Jaakko J. Kopra, Giorgio Turconi, Nadine Schweizer, Erika Bereczki, Fredrik Piehl, Göran Engberg, Simon Cervenka, T. Petteri Piepponen, Fu-Ping Zhang, Petra Sipilä, Johan Jakobsson, Carl M. Sellgren, Sophie Erhardt, Jaan-Olle Andressoo",
                "Journal": "Molecular Psychiatry",
                "GeneSymbolName": "gdnf"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "jak1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "janus kinase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 8704,
            "Article": [
              {
                "PCLID": 37597151,
                "RelevanceScore": 807029,
                "PMID": 39139787,
                "DOI": "10.3389/fmed.2024.1402902",
                "PublicationDate": "2024-07-30",
                "IsReview": false,
                "Title": "A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review",
                "Author": "François Poumeaud, Marion Jaffrelot, Carlos Gomez-Roca, Iphigénie Korakis, Giulia Leonardi, Marine Joly, Julien Mazières, Rosine Guimbaud, Nadim Fares, Emily Alouani",
                "Journal": "Frontiers in Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "jak1"
              },
              {
                "PCLID": 36586242,
                "RelevanceScore": 474723,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "jak1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "gpt"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "glutamic--pyruvic transaminase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 8697,
            "Article": [
              {
                "PCLID": 37823775,
                "RelevanceScore": 544616,
                "PMID": 39372206,
                "DOI": "10.3389/fphar.2024.1424980",
                "PublicationDate": "2024-09-20",
                "IsReview": false,
                "Title": "Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system",
                "Author": "Qiong Jie, Yuanyuan Li, Li Jing, Jinjin Chen, Yang Li",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38084636,
                "RelevanceScore": 320362,
                "PMID": 39630530,
                "DOI": "10.1089/thy.2024.0495",
                "PublicationDate": "2025-01-01",
                "IsReview": false,
                "Title": "Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma",
                "Author": "Sarah Hamidi, Sireesha Yedururi, Mimi I. Hu, Naifa L. Busaidy, Steven I. Sherman, Camilo Jimenez, Elizabeth G. Grubbs, Anastasios Maniakas, Mark E. Zafereo, Vivek Subbiah, Steven G. Waguespack",
                "Journal": "Thyroid : official journal of the American Thyroid Association",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35057669,
                "RelevanceScore": 228830,
                "PMID": 36422787,
                "DOI": "10.1007/s11523-022-00935-5",
                "PublicationDate": "2022-11-24",
                "IsReview": true,
                "Title": "Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC",
                "Author": "Tina Nie, Yahiya Y. Syed",
                "Journal": "Targeted Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "isoc1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "isochorismatase domain containing 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 8405,
            "Article": [
              {
                "PCLID": 36114199,
                "RelevanceScore": 924388,
                "PMID": 37876974,
                "DOI": "10.3389/fonc.2023.1264231",
                "PublicationDate": "2023-10-09",
                "IsReview": false,
                "Title": "Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report",
                "Author": "Caio Abner Leite, Raíssa Pierri Carvalho, Felipe Marques da Costa, Augusto Kreling Medeiros, Fabio Augusto Schutz, William Nassib William",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "isoc1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "foxj3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "forkhead box j3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 8311,
            "Article": [
              {
                "PCLID": 39735543,
                "RelevanceScore": 1662030,
                "PMID": 41202951,
                "DOI": "10.1016/j.canlet.2025.218100",
                "PublicationDate": "2026-01-01",
                "IsReview": false,
                "Title": "Identification of a novel RET::FOXJ3 fusion in lung adenocarcinoma associated with lack of response to pralsetinib",
                "Author": "Ping Wang, Hao Xi Lucas Tang, Jiaqin Song, Yuyan Yang, Yao Yao, Lei Xia",
                "Journal": "Cancer Letters",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "foxj3"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "alk"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "alk receptor tyrosine kinase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 8176,
            "Article": [
              {
                "PCLID": 36331814,
                "RelevanceScore": 615865,
                "PMID": 37600327,
                "DOI": "10.3892/ol.2023.13993",
                "PublicationDate": "2023-08-02",
                "IsReview": false,
                "Title": "Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report",
                "Author": "Yinghui Bi, Chaoran Xia, Xinglin Zhang, Haixin Liu",
                "Journal": "Oncology Letters",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 109976,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 91647,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "rufy1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "run and fyve domain containing 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7989,
            "Article": [
              {
                "PCLID": 38356789,
                "RelevanceScore": 878641,
                "PMID": 39907599,
                "DOI": "10.18632/oncotarget.28682",
                "PublicationDate": "2025-02-05",
                "IsReview": false,
                "Title": "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report",
                "Author": "Jenny L. Wu, Wade T. Iams",
                "Journal": "Oncotarget",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "rufy1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tas2r38"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "taste 2 receptor member 38",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 7917,
            "Article": [
              {
                "PCLID": 35768166,
                "RelevanceScore": 401889,
                "PMID": 37219741,
                "DOI": "10.1007/s10585-023-10208-8",
                "PublicationDate": "2023-05-23",
                "IsReview": false,
                "Title": "Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer",
                "Author": "Ladislaia Wolff, Ariane Steindl, Petar Popov, Karin Dieckmann, Brigitte Gatterbauer, Georg Widhalm, Anna Sophie Berghoff, Matthias Preusser, Markus Raderer, Barbara Kiesewetter",
                "Journal": "Clinical & Experimental Metastasis"
              },
              {
                "PCLID": 10250207,
                "RelevanceScore": 348747,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35118347,
                "RelevanceScore": 255748,
                "PMID": 36527599,
                "DOI": "10.1007/s40801-022-00346-y",
                "PublicationDate": "2022-12-17",
                "IsReview": false,
                "Title": "Multikinase Inhibitor Treatment Patterns for Advanced Thyroid Cancer in Japan: An Administrative Claims Database Study",
                "Author": "Chie Masaki, Kiminori Sugino, Yoshinori Tanizawa, Kenichi Nakamura, Yui Okada, Zhihong Cai, Takahiro Okamoto",
                "Journal": "Drugs - Real World Outcomes"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tg"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "thyroglobulin",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 7897,
            "Article": [
              {
                "PCLID": 9572982,
                "RelevanceScore": 420279,
                "PMID": 34583388,
                "DOI": "10.1055/a-1580-7327",
                "PublicationDate": "2022-04-01",
                "IsReview": false,
                "Title": "[Treatment strategy by radioiodine refractory differentiated thyroid cancer]",
                "Author": "Konstantinos Mantsopoulos, Sarina K Mueller, Marianne Pavel, Torsten Kuwert, Norbert Meidenbauer, Rainer Fietkau, Matti Sievert, Heinrich Iro",
                "Journal": "Laryngo- rhino- otologie",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 37736596,
                "RelevanceScore": 210139,
                "PMID": 39278941,
                "DOI": "10.1186/s13044-024-00209-4",
                "PublicationDate": "2024-09-16",
                "IsReview": false,
                "Title": "Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements",
                "Author": "Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, Nobuyuki Hirai, Eiji Kobayashi, Yosuke Nakanishi, Satoru Kondo, Tomokazu Yoshizaki",
                "Journal": "Thyroid Research"
              },
              {
                "PCLID": 10250207,
                "RelevanceScore": 175116,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "gfer"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "growth factor, augmenter of liver regeneration",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 7881,
            "Article": [
              {
                "PCLID": 37038083,
                "RelevanceScore": 650063,
                "PMID": 38584556,
                "DOI": "10.2174/0118715206290110240326071909",
                "PublicationDate": "2024-07-01",
                "IsReview": false,
                "Title": "Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS)",
                "Author": "Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang",
                "Journal": "Anti-Cancer Agents in Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 36365086,
                "RelevanceScore": 246236,
                "PMID": 37979367,
                "DOI": "10.1016/j.jchromb.2023.123918",
                "PublicationDate": "2023-12-01",
                "IsReview": false,
                "Title": "Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs",
                "Author": "Paul D. Kruithof, Yvo M. de Beer, Judith L. Gulikers, Leo M.L. Stolk, Lizza E.L. Hendriks, Sander Croes, Robin M.J.M. van Geel",
                "Journal": "Journal of chromatography. B, Analytical technologies in the biomedical and life sciences",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "tacc3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "transforming acidic coiled-coil containing protein 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 7828,
            "Article": [
              {
                "PCLID": 37155542,
                "RelevanceScore": 701547,
                "PMID": 38696710,
                "DOI": "10.1097/cad.0000000000001618",
                "PublicationDate": "2024-04-29",
                "IsReview": false,
                "Title": "Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition",
                "Author": "Adam Barsouk, Omar Elghawy, Sara Stone, Aditi Singh",
                "Journal": "Anti-Cancer Drugs",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "tacc3"
              },
              {
                "PCLID": 12938073,
                "RelevanceScore": 159442,
                "PMID": 34508169,
                "DOI": "10.1038/s41698-021-00221-z",
                "PublicationDate": "2021-09-10",
                "IsReview": false,
                "Title": "Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions",
                "Author": "Binghao Li, Hao Qu, Jing Zhang, Weibo Pan, Meng Liu, Xiaobo Yan, Xin Huang, Xuexin He, Dong Lin, Sisi Liu, Ruting Guan, Yong Wu, Qiuxiang Ou, Hua Bao, Youbin Xu, Xue Wu, Yang Shao, Nong Lin",
                "Journal": "npj Precision Oncology",
                "GeneSymbolName": "tacc3"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ntrk3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "neurotrophic receptor tyrosine kinase 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 7783,
            "Article": [
              {
                "PCLID": 36897636,
                "RelevanceScore": 499351,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ntrk3"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 363165,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ntrk3"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 97276,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "fgfr1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "fibroblast growth factor receptor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 7782,
            "Article": [
              {
                "PCLID": 38465142,
                "RelevanceScore": 313874,
                "PMID": 40016191,
                "DOI": "10.1038/s41392-025-02155-5",
                "PublicationDate": "2025-02-28",
                "IsReview": false,
                "Title": "Safety, pharmacokinetics and efficacy of HA121-28 in patients with advanced solid tumors and RET fusion-positive non-small-cell lung cancer: a multicenter, open-label, single-arm phase 1/2 trial",
                "Author": "Dan-Yun Ruan, Wen-Wen Huang, Yongsheng Li, Yanqiu Zhao, Yehui Shi, Yuming Jia, Shundong Cang, Wei Zhang, Jianhua Shi, Jun Chen, Jie Lin, Yunpeng Liu, Jianming Xu, Weiwei Ouyang, Jian Fang, Wu Zhuang, Caigang Liu, Qing Bu, Manxiang Li, Xiangjiao Meng, Meili Sun, Nong Yang, Xiaorong Dong, Yueyin Pan, Xingya Li, Xiujuan Qu, Tongmei Zhang, Xianglin Yuan, Sheng Hu, Wei Guo, Yalun Li, Shengqing Li, Dongying Liu, Feixue Song, Liping Tan, Yan Yu, Xinmin Yu, Aimin Zang, Chang Sun, Qian Zhang, Kai Zou, Mo Dan, Rui-Hua Xu, Hongyun Zhao",
                "Journal": "Signal Transduction and Targeted Therapy"
              },
              {
                "PCLID": 35304373,
                "RelevanceScore": 201402,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "fgfr1"
              },
              {
                "PCLID": 38889347,
                "RelevanceScore": 137320,
                "PMID": 40452844,
                "DOI": "10.3389/fonc.2025.1477910",
                "PublicationDate": "2025-05-16",
                "IsReview": false,
                "Title": "RET fusion driven (RETfus+) non-small cell lung cancer: a comprehensive genomic profiling study with histologic correlation",
                "Author": "Prashanth Ashok Kumar, Michael Connolly, Alina Basnet, Dean Pavlick, Richard Huang, Steven Graziano, Jeffrey Ross",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "fgfr1"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 78468,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 65390,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "kif13a"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "kinesin family member 13a",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7780,
            "Article": [
              {
                "PCLID": 37535647,
                "RelevanceScore": 1555889,
                "PMID": 39057153,
                "DOI": "10.3390/curroncol31070281",
                "PublicationDate": "2024-06-30",
                "IsReview": false,
                "Title": "A Locally Advanced NSCLC Patient Harboring a Rare KIF13A-RET Fusion Benefited from Pralsetinib: A Case Report",
                "Author": "Zenghao Chang, Tengfei Zhu, Hao Jiang, Wei Ou, Siyu Wang",
                "Journal": "Current oncology (Toronto, Ont.)",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "kif13a"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "smug1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "single-strand-selective monofunctional uracil-dna glycosylase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 7729,
            "Article": [
              {
                "PCLID": 35171699,
                "RelevanceScore": 426207,
                "PMID": 36327463,
                "DOI": "10.1097/rlu.0000000000004475",
                "PublicationDate": "2022-11-11",
                "IsReview": false,
                "Title": "Reversing \"Flip-Flop\" Phenomenon of 131 I and Glucose Avidity in RET-Fusion Positive Radioiodine-Refractory Thyroid Cancer Lesions After Treatment of Pralsetinib",
                "Author": "Hung-Pin Chan, I-Feng Chen, Fu-Ren Tsai, Chun-Hao Kao, Daniel Hueng-Yuan Shen",
                "Journal": "Clinical Nuclear Medicine",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 37726549,
                "RelevanceScore": 360636,
                "PMID": 39272672,
                "DOI": "10.3390/diagnostics14171886",
                "PublicationDate": "2024-08-28",
                "IsReview": false,
                "Title": "Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis",
                "Author": "Kalevi Kairemo, Homer A. Macapinlac, Mohammed Gouda, Vivek Subbiah",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 37914743,
                "RelevanceScore": 140508,
                "PMID": 39468677,
                "DOI": "10.1186/s40644-024-00791-8",
                "PublicationDate": "2024-10-28",
                "IsReview": true,
                "Title": "Role of [18F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma",
                "Author": "Klaudia Zajkowska, Paulina Cegla, Marek Dedecjus",
                "Journal": "Cancer imaging : the official publication of the International Cancer Imaging Society"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "prom2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "prominin 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7512,
            "Article": [
              {
                "PCLID": 36433397,
                "RelevanceScore": 751076,
                "PMID": 38132167,
                "DOI": "10.3390/cells12242847",
                "PublicationDate": "2023-12-15",
                "IsReview": false,
                "Title": "Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)",
                "Author": "Paul Marcoux, Jin Wook Hwang, Christophe Desterke, Jusuf Imeri, Annelise Bennaceur-Griscelli, Ali G. Turhan",
                "Journal": "Cells",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "prom2"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "lf2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "protein lf2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7453,
            "Article": [
              {
                "PCLID": 23770278,
                "RelevanceScore": 745236,
                "PMID": 35268691,
                "DOI": "10.3390/molecules27051590",
                "PublicationDate": "2022-02-28",
                "IsReview": false,
                "Title": "Designing Novel Compounds for the Treatment and Management of RET-Positive Non-Small Cell Lung Cancer—Fragment Based Drug Design Strategy",
                "Author": "Priyanka Ramesh, Shanthi Veerappapillai",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "lf2"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pibf1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "progesterone immunomodulatory binding factor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7452,
            "Article": [
              {
                "PCLID": 35954774,
                "RelevanceScore": 894137,
                "PMID": 37478265,
                "DOI": "10.1097/md.0000000000034305",
                "PublicationDate": "2023-07-21",
                "IsReview": false,
                "Title": "A novel PIBF1-RET gene fusion identified from a stage IA lung adenocarcinoma: A case report",
                "Author": "Weidi Zhao, Jia’en Sun, Huangkai Zhu, Guofang Zhao",
                "Journal": "Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "pibf1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "nrg1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "neuregulin 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 7295,
            "Article": [
              {
                "PCLID": 35590248,
                "RelevanceScore": 265061,
                "PMID": 37197619,
                "DOI": "10.21037/tlcr-22-566",
                "PublicationDate": "2023-04-28",
                "IsReview": true,
                "Title": "Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review",
                "Author": "Jiayan Chen, Chunwei Xu, Jiawen Lv, Wanjun Lu, Yixue Zhang, Dong Wang, Yong Song",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "nrg1"
              },
              {
                "PCLID": 38969075,
                "RelevanceScore": 238554,
                "PMID": 40502048,
                "DOI": "10.1101/2025.06.04.657911",
                "PublicationDate": "2025-06-07",
                "IsReview": false,
                "Title": "Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma",
                "Author": "Trista K Hinz, Anh T Le, Tristan Doan, Abby Ast, Sophia Jaramillo, Samantha Haines, Andre Navarro, Tejas Patil, Raphael A Nemenoff, Lynn E Heasley",
                "Journal": "bioRxiv : the preprint server for biology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "nrg1"
              },
              {
                "PCLID": 38590199,
                "RelevanceScore": 119277,
                "PMID": 40133478,
                "DOI": "10.1007/s00408-025-00801-x",
                "PublicationDate": "2025-03-25",
                "IsReview": true,
                "Title": "Update 2025: Management of Non‑Small-Cell Lung Cancer",
                "Author": "Hyein Jeon, Shuai Wang, Junmin Song, Harjot Gill, Haiying Cheng",
                "Journal": "Lung",
                "GeneSymbolName": "nrg1"
              },
              {
                "PCLID": 38216224,
                "RelevanceScore": 106498,
                "PMID": 39762686,
                "DOI": "10.1007/s12029-024-01149-w",
                "PublicationDate": "2025-01-06",
                "IsReview": true,
                "Title": "Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma",
                "Author": "Tuan Hoang, Erica S. Tsang",
                "Journal": "Journal of Gastrointestinal Cancer",
                "GeneSymbolName": "nrg1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "c1qtnf6"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "c1q and tnf related 6",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7266,
            "Article": [
              {
                "PCLID": 36433397,
                "RelevanceScore": 726540,
                "PMID": 38132167,
                "DOI": "10.3390/cells12242847",
                "PublicationDate": "2023-12-15",
                "IsReview": false,
                "Title": "Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)",
                "Author": "Paul Marcoux, Jin Wook Hwang, Christophe Desterke, Jusuf Imeri, Annelise Bennaceur-Griscelli, Ali G. Turhan",
                "Journal": "Cells",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "c1qtnf6"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "sema5a"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "semaphorin 5a",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7254,
            "Article": [
              {
                "PCLID": 35092322,
                "RelevanceScore": 1450578,
                "PMID": 36451418,
                "DOI": "10.1097/md.0000000000031480",
                "PublicationDate": "2022-11-25",
                "IsReview": false,
                "Title": "Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report",
                "Author": "Linping Gu, Wenxiang Ji, Yunhua Xu, Yuchen Han, Hong Jian",
                "Journal": "Medicine",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "sema5a"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "nrg3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "neuregulin 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7219,
            "Article": [
              {
                "PCLID": 34148626,
                "RelevanceScore": 866218,
                "PMID": 35751411,
                "DOI": "10.1177/03000605221105368",
                "PublicationDate": "2022-06-01",
                "IsReview": false,
                "Title": "Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report",
                "Author": "Xiangming Cao, Xiongwei Liu, Simin Wang, Zhen Liu, Xin Ren, Debin Sun, Lichun Deng",
                "Journal": "The Journal of international medical research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "nrg3"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "esr1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "estrogen receptor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 7208,
            "Article": [
              {
                "PCLID": 36586242,
                "RelevanceScore": 1008950,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "esr1"
              },
              {
                "PCLID": 35947600,
                "RelevanceScore": 612577,
                "PMID": 37071495,
                "DOI": "10.1158/0008-5472.can-22-3484",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer",
                "Author": "Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt, Diana Fandino, Craig T. Vollert, Purba Singh, Mohammad A. Alzubi, Anna Malovannaya, Lacey E. Dobrolecki, Michael T. Lewis, Shunqiang Li, Charles E. Foulds, Matthew J. Ellis",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "esr1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "hhv4tp2_gp70"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "lf1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7202,
            "Article": [
              {
                "PCLID": 23770278,
                "RelevanceScore": 720132,
                "PMID": 35268691,
                "DOI": "10.3390/molecules27051590",
                "PublicationDate": "2022-02-28",
                "IsReview": false,
                "Title": "Designing Novel Compounds for the Treatment and Management of RET-Positive Non-Small Cell Lung Cancer—Fragment Based Drug Design Strategy",
                "Author": "Priyanka Ramesh, Shanthi Veerappapillai",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ec:2.5.1.22"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "spermine synthase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7164,
            "Article": [
              {
                "PCLID": 39667339,
                "RelevanceScore": 859545,
                "PMID": 41244832,
                "DOI": "10.3389/fphar.2025.1671798",
                "PublicationDate": "2025-10-31",
                "IsReview": false,
                "Title": "The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production",
                "Author": "Lingyun Ma, Hang Gong, Wei Sun, Jialing Deng, Qinghua Zhang, Jianzhao Niu, Huimin Sun, Xue Han, Tingting Du, Nina Xue, Ming Ji, Qian Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "cacybp"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "calcyclin binding protein",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 7092,
            "Article": [
              {
                "PCLID": 34035054,
                "RelevanceScore": 779980,
                "PMID": 35705526,
                "DOI": "10.1158/0008-5472.can-22-0047",
                "PublicationDate": "2022-06-15",
                "IsReview": false,
                "Title": "MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET",
                "Author": "Ankit Srivastava, Cristina Tommasi, Dane Sessions, Angela Mah, Tomas Bencomo, Jasmine M. Garcia, Tiffany Jiang, Michael Lee, Joseph Y. Shen, Lek Wei Seow, Audrey Nguyen, Kimal Rajapakshe, Cristian Coarfa, Kenneth Y. Tsai, Vanessa Lopez-Pajares, Carolyn S. Lee",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cacybp"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "flt3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "fms related receptor tyrosine kinase 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 5,
            "CooccurrenceScore": 7074,
            "Article": [
              {
                "PCLID": 35304373,
                "RelevanceScore": 249153,
                "PMID": 36185300,
                "DOI": "10.3389/fonc.2022.953013",
                "PublicationDate": "2022-09-14",
                "IsReview": false,
                "Title": "Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020",
                "Author": "Jeffrey J. Kooijman, Wilhelmina E. van Riel, Jelle Dylus, Martine B. W. Prinsen, Yvonne Grobben, Tessa J. J. de Bitter, Antoon M. van Doornmalen, Janneke J. T. M. Melis, Joost C. M. Uitdehaag, Yugo Narumi, Yusuke Kawase, Jeroen A. D. M. de Roos, Nicole Willemsen-Seegers, Guido J. R. Zaman",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "flt3"
              },
              {
                "PCLID": 39348705,
                "RelevanceScore": 200783,
                "PMID": 40913959,
                "DOI": "10.1016/j.bioorg.2025.108948",
                "PublicationDate": "2025-10-01",
                "IsReview": true,
                "Title": "Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies",
                "Author": "Ting Wang, Wenjie Jiang, Liyan Yang, Jinqi Li, Yiqi Sun, Jianyou Shi",
                "Journal": "Bioorganic Chemistry",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "flt3"
              },
              {
                "PCLID": 2007155,
                "RelevanceScore": 182530,
                "PMID": 34058344,
                "DOI": "10.1016/j.bmcl.2021.128149",
                "PublicationDate": "2021-09-01",
                "IsReview": false,
                "Title": "Discovery and optimization of selective RET inhibitors via scaffold hopping",
                "Author": "Zhibo Luo, Lingli Wang, Zhifei Fu, Bin Shuai, Miaorong Luo, Guoping Hu, Jian Chen, Jikui Sun, Jiansong Wang, Jian Li, Shuhui Chen, Yang Zhang",
                "Journal": "Bioorganic & Medicinal Chemistry Letters"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 82139,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 68449,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "gli1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "gli family zinc finger 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 6838,
            "Article": [
              {
                "PCLID": 35656580,
                "RelevanceScore": 1615335,
                "PMID": 37301138,
                "DOI": "10.1016/j.biopha.2023.114995",
                "PublicationDate": "2023-08-01",
                "IsReview": false,
                "Title": "Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance",
                "Author": "Sofia Trocchianesi, Agnese Po, Anna Citarella, Zaira Spinello, Aurelia Rughetti, Zein Mersini Besharat, Tanja Milena Autilio, Valeria Pecce, Antonella Verrienti, Rossella Elisei, Cosimo Durante, Giuseppina Catanzaro, Elisabetta Ferretti",
                "Journal": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "gli1"
              },
              {
                "PCLID": 39348705,
                "RelevanceScore": 349640,
                "PMID": 40913959,
                "DOI": "10.1016/j.bioorg.2025.108948",
                "PublicationDate": "2025-10-01",
                "IsReview": true,
                "Title": "Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies",
                "Author": "Ting Wang, Wenjie Jiang, Liyan Yang, Jinqi Li, Yiqi Sun, Jianyou Shi",
                "Journal": "Bioorganic Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "dicer1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "dicer 1, ribonuclease iii",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 6832,
            "Article": [
              {
                "PCLID": 35725428,
                "RelevanceScore": 409881,
                "PMID": 37160531,
                "DOI": "10.1007/s12022-023-09764-2",
                "PublicationDate": "2023-05-09",
                "IsReview": true,
                "Title": "Thyroid Nodules and Follicular Cell-Derived Thyroid Carcinomas in Children",
                "Author": "Jonathan C. Slack, Monica Hollowell, Justine A. Barletta",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "dicer1"
              },
              {
                "PCLID": 38421735,
                "RelevanceScore": 341568,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "dicer1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ccdc30"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "coiled-coil domain containing 30",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6757,
            "Article": [
              {
                "PCLID": 38421735,
                "RelevanceScore": 810693,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "ccdc30"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "siah1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "siah e3 ubiquitin protein ligase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6725,
            "Article": [
              {
                "PCLID": 34035054,
                "RelevanceScore": 672428,
                "PMID": 35705526,
                "DOI": "10.1158/0008-5472.can-22-0047",
                "PublicationDate": "2022-06-15",
                "IsReview": false,
                "Title": "MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET",
                "Author": "Ankit Srivastava, Cristina Tommasi, Dane Sessions, Angela Mah, Tomas Bencomo, Jasmine M. Garcia, Tiffany Jiang, Michael Lee, Joseph Y. Shen, Lek Wei Seow, Audrey Nguyen, Kimal Rajapakshe, Cristian Coarfa, Kenneth Y. Tsai, Vanessa Lopez-Pajares, Carolyn S. Lee",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "siah1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "bend7"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ben domain containing 7",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6693,
            "Article": [
              {
                "PCLID": 38421735,
                "RelevanceScore": 803016,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "bend7"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "stk11"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "serine/threonine kinase 11",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 6557,
            "Article": [
              {
                "PCLID": 35940038,
                "RelevanceScore": 357612,
                "PMID": 37347391,
                "DOI": "10.1007/s11523-023-00974-6",
                "PublicationDate": "2023-06-22",
                "IsReview": false,
                "Title": "Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours",
                "Author": "Chih-Chieh Yen, Yu-Min Yeh, Hsuan-Yi Huang, Yu-Lin Ting, Pei-An Fu, Tzu-Chien Lin, I-Ting Liu, Chia-Jui Yen",
                "Journal": "Targeted Oncology",
                "GeneSymbolName": "stk11"
              },
              {
                "PCLID": 37225707,
                "RelevanceScore": 298010,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "stk11"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "sms"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "spermine synthase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6444,
            "Article": [
              {
                "PCLID": 39667339,
                "RelevanceScore": 773133,
                "PMID": 41244832,
                "DOI": "10.3389/fphar.2025.1671798",
                "PublicationDate": "2025-10-31",
                "IsReview": false,
                "Title": "The RET inhibitor pralsetinib suppresses TMZ-resistant glioma growth by regulating spermine production",
                "Author": "Lingyun Ma, Hang Gong, Wei Sun, Jialing Deng, Qinghua Zhang, Jianzhao Niu, Huimin Sun, Xue Han, Tingting Du, Nina Xue, Ming Ji, Qian Liu",
                "Journal": "Frontiers in Pharmacology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ec:2.5.1.22"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "gins2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "gins complex subunit 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6394,
            "Article": [
              {
                "PCLID": 39735543,
                "RelevanceScore": 1022851,
                "PMID": 41202951,
                "DOI": "10.1016/j.canlet.2025.218100",
                "PublicationDate": "2026-01-01",
                "IsReview": false,
                "Title": "Identification of a novel RET::FOXJ3 fusion in lung adenocarcinoma associated with lack of response to pralsetinib",
                "Author": "Ping Wang, Hao Xi Lucas Tang, Jiaqin Song, Yuyan Yang, Yao Yao, Lei Xia",
                "Journal": "Cancer Letters",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "erc1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "elks/rab6-interacting/cast family member 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 6190,
            "Article": [
              {
                "PCLID": 5424281,
                "RelevanceScore": 742700,
                "PMID": 34733735,
                "DOI": "10.21037/gs-21-469",
                "PublicationDate": "2021-09-01",
                "IsReview": false,
                "Title": "Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma",
                "Author": "Jia Ma, Baosheng Wang, Erhong Meng, Xiangpeng Meng",
                "Journal": "Gland Surgery",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "erc1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pdgfra"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "platelet derived growth factor receptor alpha",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 6123,
            "Article": [
              {
                "PCLID": 38504091,
                "RelevanceScore": 461197,
                "PMID": 40063337,
                "DOI": "10.1080/07391102.2025.2472231",
                "PublicationDate": "2025-03-10",
                "IsReview": false,
                "Title": "Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer",
                "Author": "Darakhshan Parveen, Faizul Azam, M. Mumtaz Alam, Ruhi Ali, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Shyama Charan, Suruchi Khanna, Mohd. Parvez, Mohammad Shaquiquzzaman",
                "Journal": "Journal of Biomolecular Structure and Dynamics",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "pdgfra"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 82357,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 68631,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "fgfr2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "fibroblast growth factor receptor 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 4,
            "CooccurrenceScore": 6063,
            "Article": [
              {
                "PCLID": 37225707,
                "RelevanceScore": 300592,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "fgfr2"
              },
              {
                "PCLID": 35780979,
                "RelevanceScore": 140276,
                "PMID": 37188899,
                "DOI": "10.1038/s41571-023-00770-1",
                "PublicationDate": "2023-05-15",
                "IsReview": true,
                "Title": "Cholangiocarcinoma — novel biological insights and therapeutic strategies",
                "Author": "Sumera I. Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J. Gores",
                "Journal": "Nature reviews. Clinical oncology",
                "GeneSymbolName": "fgfr2"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 90177,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35285560,
                "RelevanceScore": 75148,
                "PMID": 36395392,
                "DOI": "10.1021/acs.jmedchem.2c01361",
                "PublicationDate": "2022-11-17",
                "IsReview": true,
                "Title": "Targeting Gatekeeper Mutations for Kinase Drug Discovery",
                "Author": "Yang Zhou, Shuang Xiang, Fang Yang, Xiaoyun Lu",
                "Journal": "Journal of Medicinal Chemistry"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "erbb3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "erb-b2 receptor tyrosine kinase 3",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 5928,
            "Article": [
              {
                "PCLID": 37936126,
                "RelevanceScore": 1013169,
                "PMID": 39495173,
                "DOI": "10.1158/1078-0432.ccr-24-1762",
                "PublicationDate": "2024-11-04",
                "IsReview": false,
                "Title": "YAP Regulates HER3 Signaling–Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers",
                "Author": "Yuki Katayama, Tadaaki Yamada, Keiko Tanimura, Hayato Kawachi, Masaki Ishida, Yohei Matsui, Soichi Hirai, Ryota Nakamura, Kenji Morimoto, Naoki Furuya, Sachiko Arai, Yasuhiro Goto, Yoshihiko Sakata, Kazumi Nishino, Michiko Tsuchiya, Akihiro Tamiya, Go Saito, Satoshi Muto, Takayuki Takeda, Koji Date, Yasuhito Fujisaka, Satoshi Watanabe, Daichi Fujimoto, Hisanori Uehara, Mano Horinaka, Toshiyuki Sakai, Seiji Yano, Shinsaku Tokuda, Koichi Takayama",
                "Journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 34031418,
                "RelevanceScore": 86154,
                "PMID": 35412115,
                "DOI": "10.1007/s40265-022-01698-z",
                "PublicationDate": "2022-04-12",
                "IsReview": true,
                "Title": "Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer",
                "Author": "Manan P. Shah, Joel W. Neal",
                "Journal": "Drugs"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "cd74"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cd74 molecule",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5792,
            "Article": [
              {
                "PCLID": 38356789,
                "RelevanceScore": 636983,
                "PMID": 39907599,
                "DOI": "10.18632/oncotarget.28682",
                "PublicationDate": "2025-02-05",
                "IsReview": false,
                "Title": "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report",
                "Author": "Jenny L. Wu, Wade T. Iams",
                "Journal": "Oncotarget",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cd74"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "crbn"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cereblon",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5624,
            "Article": [
              {
                "PCLID": 39263504,
                "RelevanceScore": 562287,
                "PMID": 40823490,
                "DOI": "10.1039/d5md00337g",
                "PublicationDate": "2025-08-13",
                "IsReview": false,
                "Title": "Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degrader",
                "Author": "Douglas L. Orsi, Kiel E. Lazarski, Reina Improgo, R. V. Agafonov, Jae Young Ahn, Joelle Baddour, Katelyn Cassidy, Prasoon Chaturvedi, Kyle S. Cole, Richard W. Deibler, W. Austin Elam, Mark E. Fitzgerald, Victoria J. Garza, Andrew Good, Christopher H. Hulton, Marta Isasa, Katrina L. Jackson, Ping Li, Yanke Liang, Ryan E. Michael, Morgan Welzel O'Shea, Moses Moustakim, Samantha Perino, Fazlur Rahman, Matthew J. Schnaderbeck, Nicholas P. Stone, Bonnie Tillotson, Gesine K. Veits, Abigail Vogelaar, Jeremy L. Yap, Robert T. Yu, Hongwei Huang, James A. Henderson",
                "Journal": "RSC Medicinal Chemistry",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "crbn"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "aff1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "alf transcription elongation factor 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5612,
            "Article": [
              {
                "PCLID": 38504091,
                "RelevanceScore": 561125,
                "PMID": 40063337,
                "DOI": "10.1080/07391102.2025.2472231",
                "PublicationDate": "2025-03-10",
                "IsReview": false,
                "Title": "Monotherapy vs combination therapy evaluation of FDA-approved TKIs targeting PDGFR for the treatment of thyroid cancer",
                "Author": "Darakhshan Parveen, Faizul Azam, M. Mumtaz Alam, Ruhi Ali, Mymoona Akhter, Suhel Parvez, Mohammad Ahmed Khan, Shyama Charan, Suruchi Khanna, Mohd. Parvez, Mohammad Shaquiquzzaman",
                "Journal": "Journal of Biomolecular Structure and Dynamics",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "podxl"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "podocalyxin like",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5506,
            "Article": [
              {
                "PCLID": 38940995,
                "RelevanceScore": 715622,
                "PMID": 40496186,
                "DOI": "10.1039/d5md00245a",
                "PublicationDate": "2025-08-13",
                "IsReview": false,
                "Title": "Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy",
                "Author": "Ujjwol Khatri, Neetu Dayal, Kofi B. Owusu, Mandeep Kaur Hunjan, Shriya Pandey, Haley Anne Harper, Carli McMahan, Bennett D. Elzey, Tao Shen, Xueqing Hu, Kurt W. Evans, Ahmed El-Sheikh, Seong jun Jo, Frederick W. Holtsberg, M. Javad Aman, Funda Meric-Bernstam, Sukyung Woo, Herman O. Sintim, Jie Wu",
                "Journal": "RSC Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "flt4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "fms related receptor tyrosine kinase 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 5501,
            "Article": [
              {
                "PCLID": 36586242,
                "RelevanceScore": 543481,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "flt4"
              },
              {
                "PCLID": 21703593,
                "RelevanceScore": 97050,
                "PMID": 34402300,
                "DOI": "10.1021/acs.jmedchem.0c02167",
                "PublicationDate": "2021-08-17",
                "IsReview": true,
                "Title": "Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development",
                "Author": "Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett",
                "Journal": "Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ank1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ankyrin 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5397,
            "Article": [
              {
                "PCLID": 33946432,
                "RelevanceScore": 1079178,
                "PMID": 35571397,
                "DOI": "10.21037/atm-22-1237",
                "PublicationDate": "2022-04-01",
                "IsReview": false,
                "Title": "Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report",
                "Author": "Yan Meng, Lulu Li, Huan Wang, Xiaofang Chen, Yali Yue, Meiqing Wang, Lingru Meng, Bafei Li, Xiao Li",
                "Journal": "Annals of Translational Medicine",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "sstr2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "somatostatin receptor 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5392,
            "Article": [
              {
                "PCLID": 35183605,
                "RelevanceScore": 539147,
                "PMID": 36890425,
                "DOI": "10.1007/s12022-023-09753-5",
                "PublicationDate": "2023-03-01",
                "IsReview": true,
                "Title": "Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma",
                "Author": "Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete",
                "Journal": "Endocrine Pathology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "sstr2"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "dlg5"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "discs large maguk scaffold protein 5",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5325,
            "Article": [
              {
                "PCLID": 38421735,
                "RelevanceScore": 638928,
                "PMID": 39982551,
                "DOI": "10.1007/s12022-025-09850-7",
                "PublicationDate": "2025-02-21",
                "IsReview": false,
                "Title": "Identification of Oncogenic Alterations in 124 Cases of Pediatric Papillary Thyroid Carcinoma: BEND7::ALK, DLG5::RET, and CCDC30::ROS1 Fusions Induce MAPK Pathway Activation",
                "Author": "Yixuan Liu, Longnv Bao, Guangqi Li, Weimao Kong, Xueqing Li, Jingnan Wang, Xingzhu Pan, Zhen Zhang, Jigang Wang",
                "Journal": "Endocrine Pathology",
                "GeneSymbolName": "dlg5"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "ap1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "agamous-like mads-box protein ap1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5197,
            "Article": [
              {
                "PCLID": 38843277,
                "RelevanceScore": 623543,
                "PMID": 40405293,
                "DOI": "10.1186/s13046-025-03392-w",
                "PublicationDate": "2025-05-22",
                "IsReview": false,
                "Title": "AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors",
                "Author": "Daniela Esposito, Claudia Maria Ascione, Stefania Belli, Fabiana Napolitano, Alberto Servetto, Felice Pepe, Umberto Malapelle, Antonino Iaccarino, Giancarlo Troncone, Diletta Barone, Emilio Bria, Roberto Ferrara, Daniele Lorenzini, Giuseppe Lo Russo, Maria Rosa Ghigna, Arianna Marinello, Mihaela Aldea, Benjamin Besse, Luigi Formisano, Roberto Bianco",
                "Journal": "Journal of experimental & clinical cancer research : CR",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "ap1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "brd4"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "bromodomain containing 4",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5163,
            "Article": [
              {
                "PCLID": 32529027,
                "RelevanceScore": 516180,
                "PMID": 34518294,
                "DOI": "10.1158/1535-7163.mct-21-0127",
                "PublicationDate": "2021-09-13",
                "IsReview": false,
                "Title": "The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation",
                "Author": "Yuchen Jiang, Xia Peng, Yinchun Ji, Yang Dai, Yanfen Fang, Bing Xiong, Wenming Ren, Youhong Hu, Yi Chen, Jing Ai",
                "Journal": "Molecular Cancer Therapeutics",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "brd4"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "yap1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "yes1 associated transcriptional regulator",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5148,
            "Article": [
              {
                "PCLID": 35947600,
                "RelevanceScore": 772025,
                "PMID": 37071495,
                "DOI": "10.1158/0008-5472.can-22-3484",
                "PublicationDate": "2023-04-18",
                "IsReview": false,
                "Title": "Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer",
                "Author": "Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt, Diana Fandino, Craig T. Vollert, Purba Singh, Mohammad A. Alzubi, Anna Malovannaya, Lacey E. Dobrolecki, Michael T. Lewis, Shunqiang Li, Charles E. Foulds, Matthew J. Ellis",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "yap1"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "trim33"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "tripartite motif containing 33",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5011,
            "Article": [
              {
                "PCLID": 35887675,
                "RelevanceScore": 901733,
                "PMID": 37139148,
                "DOI": "10.3389/fonc.2023.1078076",
                "PublicationDate": "2023-04-17",
                "IsReview": false,
                "Title": "RET rearrangement-positive pancreatic cancer has remarkable response to pralsetinib: a case report",
                "Author": "Tongyi Zhang, Hongwei Wang, Zhiwei Cai, Siqi Zhang, Chongyi Jiang",
                "Journal": "Frontiers in Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "trim33"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "shc1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "shc adaptor protein 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 5006,
            "Article": [
              {
                "PCLID": 38361527,
                "RelevanceScore": 550525,
                "PMID": 39879936,
                "DOI": "10.1016/j.ejmech.2025.117294",
                "PublicationDate": "2025-03-15",
                "IsReview": false,
                "Title": "Design, synthesis and evaluation of (E)-1-(4-(2-(1H-pyrazol-5-yl)vinyl)phenyl) derivatives as next generation selective RET inhibitors overcoming RET solvent front mutations (G810C/R)",
                "Author": "Mingjin Xu, Kaifu Wu, Rui He, Jiahuan He, Gangpeng Yang, Haowen Ma, Lijie Peng, Shuyao Zhang, Li Tan, Zhang Zhang, Qian Cai",
                "Journal": "European Journal of Medicinal Chemistry",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "nkx2-1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "nk2 homeobox 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4961,
            "Article": [
              {
                "PCLID": 25155571,
                "RelevanceScore": 495972,
                "PMID": 35242632,
                "DOI": "10.21037/tlcr-21-571",
                "PublicationDate": "2022-01-01",
                "IsReview": false,
                "Title": "Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report",
                "Author": "Vincent Yeung, Chul Kim, Lesli A. Kiedrowski, Stephen V. Liu, Joshua E. Reuss",
                "Journal": "Translational Lung Cancer Research",
                "ChemicalName": "pralsetinib"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "etv6"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ets variant transcription factor 6",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4894,
            "Article": [
              {
                "PCLID": 36897636,
                "RelevanceScore": 538231,
                "PMID": 38438731,
                "DOI": "10.1038/s41698-024-00563-4",
                "PublicationDate": "2024-03-04",
                "IsReview": false,
                "Title": "Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer",
                "Author": "Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu",
                "Journal": "npj Precision Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "etv6"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "poc1b"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "poc1 centriolar protein b",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4777,
            "Article": [
              {
                "PCLID": 37225707,
                "RelevanceScore": 477646,
                "PMID": 38770091,
                "DOI": "10.1177/17588359241253113",
                "PublicationDate": "2024-01-01",
                "IsReview": false,
                "Title": "Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series",
                "Author": "Maahum Mehdi, Aniko Szabo, Aditya Shreenivas, James P. Thomas, Susan Tsai, Kathleen K. Christians, Douglas B. Evans, Callisia N. Clarke, William A. Hall, Beth Erickson, Gulrayz Ahmed, Bicky Thapa, Thomas McFall, Ben George, Razelle Kurzrock, Mandana Kamgar",
                "Journal": "Therapeutic Advances in Medical Oncology",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "poc1b"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "usp8"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "ubiquitin specific peptidase 8",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4639,
            "Article": [
              {
                "PCLID": 37299098,
                "RelevanceScore": 510150,
                "PMID": 38847983,
                "DOI": "10.1245/s10434-024-15500-9",
                "PublicationDate": "2024-06-07",
                "IsReview": false,
                "Title": "Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions",
                "Author": "Daniel W. Scholfield, Conall W. R. Fitzgerald, Lillian A. Boe, Alana Eagan, Helena Levyn, Bin Xu, R. Michael Tuttle, James A. Fagin, Ashok R. Shaha, Jatin P. Shah, Richard J. Wong, Snehal G. Patel, Ronald Ghossein, Ian Ganly",
                "Journal": "Annals of Surgical Oncology",
                "GeneSymbolName": "usp8"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "bcar3"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "bcar3 adaptor protein, nsp family member",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4605,
            "Article": [
              {
                "PCLID": 8909402,
                "RelevanceScore": 552463,
                "PMID": 35031902,
                "DOI": "10.1007/s10549-021-06452-9",
                "PublicationDate": "2022-01-15",
                "IsReview": false,
                "Title": "Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes",
                "Author": "Ana Carolina Pavanelli, Flavia Rotea Mangone, Piriya Yoganathan, Simone Aparecida Bessa, Suely Nonogaki, Cynthia A. B. de Toledo Osório, Victor Piana de Andrade, Iberê Cauduro Soares, Evandro Sobrosa de Mello, Lois M. Mulligan, Maria Aparecida Nagai",
                "Journal": "Breast Cancer Research and Treatment",
                "GeneSymbolName": "bcar3"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "hras"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "hras proto-oncogene, gtpase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 2,
            "CooccurrenceScore": 4559,
            "Article": [
              {
                "PCLID": 35043805,
                "RelevanceScore": 419751,
                "PMID": 35920918,
                "DOI": "10.1007/s00428-022-03390-9",
                "PublicationDate": "2022-08-03",
                "IsReview": false,
                "Title": "Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population",
                "Author": "Yanhua Bai, Ting Guo, Dongfeng Niu, Yanli Zhu, Wenhao Ren, Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji",
                "Journal": "Virchows Archiv : an international journal of pathology",
                "GeneSymbolName": "hras"
              },
              {
                "PCLID": 35436076,
                "RelevanceScore": 74198,
                "PMID": 36806787,
                "DOI": "10.1038/s41571-023-00733-6",
                "PublicationDate": "2023-02-20",
                "IsReview": true,
                "Title": "Rare molecular subtypes of lung cancer",
                "Author": "Guilherme Harada, Soo-Ryum Yang, Emiliano Cocco, Alexander Drilon",
                "Journal": "Nature reviews. Clinical oncology",
                "GeneSymbolName": "hras"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "abcg2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "atp binding cassette subfamily g member 2 (jr blood group)",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4390,
            "Article": [
              {
                "PCLID": 8246211,
                "RelevanceScore": 1448209,
                "PMID": 34450308,
                "DOI": "10.1016/j.phrs.2021.105850",
                "PublicationDate": "2021-10-01",
                "IsReview": false,
                "Title": "ABCB1 and ABCG2, but not CYP3A4 limit oral availability and brain accumulation of the RET inhibitor pralsetinib",
                "Author": "Yaogeng Wang, Rolf W. Sparidans, Sander Potters, Maria C. Lebre, Jos H. Beijnen, Alfred H. Schinkel",
                "Journal": "Pharmacological Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "abcg2"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "cyp2j2"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "cytochrome p450 family 2 subfamily j member 2",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4341,
            "Article": [
              {
                "PCLID": 37582541,
                "RelevanceScore": 781117,
                "PMID": 39105612,
                "DOI": "10.1080/00498254.2024.2389401",
                "PublicationDate": "2024-08-12",
                "IsReview": false,
                "Title": "Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activities",
                "Author": "Ayaka Kojima, Masayuki Nadai, Norie Murayama, Hiroshi Yamazaki, Miki Katoh",
                "Journal": "Xenobiotica; the fate of foreign compounds in biological systems",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "cyp2j2"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "pafah1b1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "platelet activating factor acetylhydrolase 1b regulatory subunit 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4334,
            "Article": [
              {
                "PCLID": 34107943,
                "RelevanceScore": 433301,
                "PMID": 35524867,
                "DOI": "10.1007/s10637-022-01246-2",
                "PublicationDate": "2022-05-07",
                "IsReview": false,
                "Title": "Identifification of a novel LDLR-RET Fusion in Lung Adenocarcinoma",
                "Author": "Guanglin Shi, Yuyan Luo, Zhaonan Yu, Yue Wang, Bojin Zhu",
                "Journal": "Investigational New Drugs"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "minpp1"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "multiple inositol-polyphosphate phosphatase 1",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 4094,
            "Article": [
              {
                "PCLID": 6166176,
                "RelevanceScore": 409253,
                "PMID": 35364706,
                "DOI": "10.1007/s00432-022-03969-4",
                "PublicationDate": "2022-04-02",
                "IsReview": false,
                "Title": "A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing: a case report",
                "Author": "Xiaoyi Xu, Haoyi Wang, Zhaonan Yu, Xianguo Chen",
                "Journal": "Journal of Cancer Research and Clinical Oncology"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "dcxr"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "dicarbonyl and l-xylulose reductase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 3977,
            "Article": [
              {
                "PCLID": 38013878,
                "RelevanceScore": 397618,
                "PMID": 39563271,
                "DOI": "10.1186/s12885-024-13155-z",
                "PublicationDate": "2024-11-19",
                "IsReview": false,
                "Title": "Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review",
                "Author": "Siyu Lei, Linyan Tian, Lu Yang, Yaning Yang, Junling Li, Xingsheng Hu, Xuezhi Hao, Haiyan Xu, Yan Wang",
                "Journal": "BMC Cancer"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "igf1r"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "insulin like growth factor 1 receptor",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 3953,
            "Article": [
              {
                "PCLID": 36586242,
                "RelevanceScore": 474223,
                "PMID": 37779428,
                "DOI": "10.1158/0008-5472.can-23-1021",
                "PublicationDate": "2023-10-02",
                "IsReview": false,
                "Title": "RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion–Positive Breast Cancer and Beyond",
                "Author": "Jie Wu, Vivek Subbiah",
                "Journal": "Cancer Research",
                "ChemicalName": "pralsetinib",
                "GeneSymbolName": "igf1r"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "met"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "met proto-oncogene, receptor tyrosine kinase",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 3,
            "CooccurrenceScore": 3951,
            "Article": [
              {
                "PCLID": 10250207,
                "RelevanceScore": 187112,
                "PMID": 35328215,
                "DOI": "10.3390/diagnostics12030662",
                "PublicationDate": "2022-03-09",
                "IsReview": true,
                "Title": "Update on International Medical Taxonomies of Biomarkers and Their Applications in Management of Thyroid Cancers",
                "Author": "Maria Trovato",
                "Journal": "Diagnostics (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 35736677,
                "RelevanceScore": 172718,
                "PMID": 37513232,
                "DOI": "10.3390/molecules28145359",
                "PublicationDate": "2023-07-12",
                "IsReview": true,
                "Title": "The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies",
                "Author": "George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu, Octavian Tudorel Olaru",
                "Journal": "Molecules (Basel, Switzerland)",
                "ChemicalName": "pralsetinib"
              },
              {
                "PCLID": 38404434,
                "RelevanceScore": 52217,
                "PMID": 39956859,
                "DOI": "10.1038/s41392-025-02129-7",
                "PublicationDate": "2025-02-17",
                "IsReview": true,
                "Title": "Molecular principles underlying aggressive cancers",
                "Author": "Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang",
                "Journal": "Signal Transduction and Targeted Therapy"
              }
            ]
          }
        }
      },
      {
        "ID_1": {
          "CID": 129073603
        },
        "ID_2": {
          "GeneSymbol": "adam15"
        },
        "Evidence": {
          "ChemicalGeneSymbolNeighbor": {
            "NeighborName": "adam metallopeptidase domain 15",
            "OrderingByCooccurrenceScore": true,
            "ArticleCount": 1,
            "CooccurrenceScore": 3877,
            "Article": [
              {
                "PCLID": 33977142,
                "RelevanceScore": 387648,
                "PMID": 35668171,
                "DOI": "10.1038/s42003-022-03514-6",
                "PublicationDate": "2022-06-06",
                "IsReview": false,
                "Title": "Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort",
                "Author": "Jing Yang, Zhilong Jia, Xinyu Song, Jinlong Shi, Xiaoreng Wang, Xiaojing Zhao, Kunlun He",
                "Journal": "Communications Biology",
                "GeneSymbolName": "adam15"
              }
            ]
          }
        }
      }
    ]
  }
}
